category,url,hero_name,hero_subtitle,hero_typical_dose,hero_route,hero_cycle,hero_storage,quick_typical_dose,quick_how_often,quick_where_to_inject,quick_injection_timing,quick_effects_timeline,quick_storage,quick_cycle_length,quick_break_between,overview,molecular_information,"research_indications_anxiety
most_effective","research_indications_cognitive
effective","research_indications_neuroprotective
moderate",research_indications,research_protocols,"peptide_interactions_selank
similar","peptide_interactions_semax
compatible","peptide_interactions_bpc-157
compatible","peptide_interactions_diazepam_(benzodiazepine)
synergistic",how_to_reconstitute,quality_indicators,what_to_expect,side_effects_&_safety,references,quick_how_to_take,quick_best_timing,"research_indications_mood
moderate","research_indications_cognitive
most_effective","research_indications_neuroprotective
effective","peptide_interactions_semax
similar","peptide_interactions_p21
synergistic","peptide_interactions_noopept
monitor_combination","research_indications_mood
effective","research_indications_weight_loss
most_effective","research_indications_metabolic
effective","research_indications_appetite_control
moderate","peptide_interactions_semaglutide_(glp‑1_ra)
monitor_combination","peptide_interactions_tirzepatide_(glp‑1/gip_ra)
monitor_combination","peptide_interactions_cagrilintide_(amylin_analog)
unknown","peptide_interactions_aod‑9604
unknown","peptide_interactions_bpc‑157
compatible","peptide_interactions_cjc‑1295_/_ipamorelin
use_caution","peptide_interactions_melanotan_ii
requires_timing","peptide_interactions_nephrotoxic_drugs_(e.g.,_high‑dose_nsaids,_aminoglycosides)_*
avoid_combination",quick_where_to_apply,"research_indications_hair_growth
most_effective","research_indications_skin_regeneration
effective","peptide_interactions_ghk-cu
synergistic","peptide_interactions_minoxidil
synergistic","peptide_interactions_finasteride_/_dutasteride
complementary","peptide_interactions_copper_supplements
avoid_combination","peptide_interactions_vitamin_c_(l-ascorbic_acid)
requires_timing","peptide_interactions_aha/bha_acids
use_caution","peptide_interactions_retinol_/_retinoids
use_caution","peptide_interactions_iron_chelators
monitor_combination","peptide_interactions_hyaluronic_acid
synergistic","research_indications_limitations
most_effective","research_indications_fat_loss
most_effective","research_indications_joint
effective","peptide_interactions_cjc-1295
compatible","peptide_interactions_ipamorelin
compatible","peptide_interactions_semaglutide
compatible","peptide_interactions_insulin
compatible","research_indications_longevity
most_effective","research_indications_metabolism
effective","research_indications_weight_loss
moderate","peptide_interactions_nad+_precursors_(nmn,_nr)
synergistic","peptide_interactions_resveratrol
synergistic","peptide_interactions_metformin
monitor_combination","peptide_interactions_blood_thinners
unknown","peptide_interactions_berberine
monitor_combination","research_indications_metabolism
most_effective","research_indications_weight_loss
effective","research_indications_longevity
moderate","research_indications_neuroplasticity
moderate","peptide_interactions_semax
synergistic","peptide_interactions_selank
synergistic","peptide_interactions_na-semax-amidate
monitor_combination","peptide_interactions_cerebrolysin
compatible","peptide_interactions_dihexa
use_caution","peptide_interactions_choline_sources
synergistic","research_indications_research
effective","research_indications_neuroprotection
most_effective","research_indications_anti_inflammatory
effective","research_indications_tissue_repair
moderate","research_indications_autoimmune
moderate","peptide_interactions_bpc-157
synergistic","peptide_interactions_tb-500
synergistic","peptide_interactions_thymosin_beta-4
compatible","peptide_interactions_epo_(erythropoietin)
avoid_combination","peptide_interactions_nad+
monitor_combination","peptide_interactions_growth_hormone
use_caution","peptide_interactions_anti-tnf_biologics
requires_timing","research_indications_diabetes
effective","research_indications_metabolic
moderate","peptide_interactions_tirzepatide
being_studied","peptide_interactions_semaglutide
avoid_combination","peptide_interactions_retatrutide
avoid_combination","peptide_interactions_5-amino-1mq
compatible","peptide_interactions_mots-c
compatible","research_indications_wound_healing
most_effective","research_indications_neurological
effective","research_indications_gastrointestinal
moderate","peptide_interactions_ghrp-6
compatible","peptide_interactions_ipamorelin
synergistic","peptide_interactions_cjc-1295
synergistic","peptide_interactions_melanotan_ii
compatible","peptide_interactions_aod-9604
compatible","peptide_interactions_l-carnitine
compatible","research_indications_gastrointestinal
most_effective","research_indications_wound_healing
effective","research_indications_neurological
moderate","peptide_interactions_semaglutide
synergistic","peptide_interactions_tirzepatide
compatible","peptide_interactions_retatrutide
use_caution","peptide_interactions_liraglutide
compatible","peptide_interactions_insulin
monitor_combination","peptide_interactions_metformin
compatible","peptide_interactions_sglt2_inhibitors
compatible","peptide_interactions_pramlintide
avoid_combination","peptide_interactions_oral_contraceptives
requires_timing"
Injectable,https://pep-pedia.org/peptides/adalank,Adalank,N-Acetyl Selank Amidate | Enhanced Tuftsin Analog,200-500mcg,Injectable,2-4 weeks,2-8°C,200-300 mcg,1-2x daily,"Belly, thigh, upper arm (subcutaneous)","Morning preferred, second dose early afternoon if needed","Days for anxiety relief, 1-2 weeks for cognitive benefits","Fridge 2-8°C, use within 14-30 days",2-4 weeks,1-2 weeks minimum to prevent tolerance,"Adalank (N-Acetyl Selank Amidate) is an enhanced synthetic derivative of Selank peptide, featuring N-terminal acetylation and C-terminal amidation for superior stability and blood-brain barrier penetration. Developed from the immunomodulatory peptide tuftsin, it's researched for anxiety reduction, cognitive enhancement, neuroprotection, and stress resilience with improved pharmacokinetic properties compared to the parent compound.
Potent anxiolytic effects, enhanced cognitive function, stress resilience, improved mood and emotional stability, neuroprotection, and immunomodulatory support. Superior bioavailability and extended half-life compared to parent compound Selank.
Adalank crosses the blood-brain barrier via enhanced lipophilicity from N-acetylation and C-terminal amidation. It modulates GABAergic neurotransmission, upregulates BDNF in the hippocampus, influences serotonin metabolism, provides immunomodulatory effects via tuftsin-derived mechanisms, and reduces stress-related neurotransmitters without benzodiazepine dependency.","Weight
792.93 Da (N-Acetyl form)
Length
7 amino acids (with modifications)
Type
Modified heptapeptide (enhanced tuftsin analog)
Amino Acid Sequence:
Ac-Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH2 (N-Acetylated and C-terminal amidated)
* N-terminal acetylation and C-terminal amidation for enhanced stability, metabolic resistance, and blood-brain barrier penetration","Generalized Anxiety Disorder (GAD)
Parent compound Selank demonstrated anxiolytic effects comparable to benzodiazepines in clinical trials with 62 GAD patients, with 40% showing rapid response within 1-3 days. N-Acetyl modification enhances these effects.
Stress-Related Anxiety
Research shows Selank reduces stress-induced anxiety through modulation of stress hormones and neurotransmitter balance, with enhanced stability in N-Acetyl form prolonging anxiolytic benefits.
Anxiety without Sedation
Unlike benzodiazepines, provides anxiety relief without sedation, amnesia, tolerance, withdrawal, or dependency - critical advantage for long-term anxiety management.","Cognitive Enhancement
Selank demonstrates nootropic and psychostimulant effects alongside anxiolytic properties. BDNF upregulation in hippocampus supports memory, learning, and cognitive function.
Memory Protection
Research confirms Selank protects against ethanol-induced memory impairment and prevents attention disturbances through BDNF-mediated neurotrophin mechanisms in hippocampus and prefrontal cortex.
Attention and Focus
Clinical studies show improvements in attention, mental clarity, and cognitive performance, particularly when combined with reduced anxiety levels.","BDNF Upregulation
Rapidly elevates Brain-Derived Neurotrophic Factor expression in hippocampus, supporting neuroplasticity, neuronal survival, and long-term cognitive health.
Anti-inflammatory Neuroprotection
Research demonstrates significant modulation of 34 inflammation-related genes, providing anti-inflammatory neuroprotection and immunomodulatory benefits.
Stress Resilience
Enhances resilience to chronic stress conditions and protects against stress-induced neurological damage through multiple neuroprotective pathways.","Parent compound Selank demonstrated anxiolytic effects comparable to benzodiazepines in clinical trials with 62 GAD patients, with 40% showing rapid response within 1-3 days. N-Acetyl modification enhances these effects.
Research shows Selank reduces stress-induced anxiety through modulation of stress hormones and neurotransmitter balance, with enhanced stability in N-Acetyl form prolonging anxiolytic benefits.
Unlike benzodiazepines, provides anxiety relief without sedation, amnesia, tolerance, withdrawal, or dependency - critical advantage for long-term anxiety management.","Disclaimer: These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing: Injectable Adalank is most effective when administered in the morning to align with natural cortisol rhythms and maximize anxiolytic benefits throughout the day. If taking twice daily, second dose should be early afternoon. Avoid evening administration to prevent potential sleep disruption.",Adalank is an enhanced derivative of Selank with improved stability and longer half-life,"Both are Russian nootropic peptides with different mechanisms - Semax for cognitive enhancement, Adalank for anxiety","Different mechanisms - Adalank targets neurological/anxiety pathways, BPC-157 focuses on tissue repair",Parent compound Selank enhances benzodiazepine effects while reducing side effects in research studies,"Important: Always use bacteriostatic water (BAC). Sterile technique is essential.
Clean work area and hands thoroughly with alcohol
Calculate required BAC water volume using calculator below
Draw calculated BAC water into syringe
Inject slowly down vial side (not directly onto powder)
Gently swirl until completely dissolved (never shake vigorously)
Store reconstituted solution in refrigerator at 2-8°C
Use within 14-30 days for optimal potency","Lyophilized Adalank should appear as white to off-white, fluffy powder filling the vial bottom. Indicates proper freeze-drying and storage.
When properly mixed with BAC water, solution should be crystal clear with no particles, cloudiness, or discoloration.
Vial should have clear labeling with peptide name (Adalank or N-Acetyl Selank Amidate), batch number, manufacturing date, and storage instructions from reputable research supplier.
Minor compaction from shipping is acceptable if powder dissolves completely with gentle swirling. Should not remain permanently clumped.
Any yellow, brown, or unusual coloration indicates oxidation, degradation, or improper storage. Adalank should be white to off-white only.
Persistent cloudiness, particles, or precipitates after gentle mixing indicate degraded, contaminated, or improperly manufactured peptide.","Days 1-3: 40% of users may experience rapid anxiety reduction (based on parent compound research)
Week 1-2: Gradual anxiety relief, improved mood, enhanced stress resilience
Week 2-4: Cognitive enhancement, improved focus, BDNF-mediated neuroplasticity
Week 4+: Sustained anxiolytic and cognitive benefits with continued use
Note: N-Acetyl form provides extended effects compared to standard Selank","Use sterile injection technique to prevent infection
CRITICAL: This is an experimental peptide with limited direct human research data on N-Acetyl form
Parent compound Selank has extensive Russian clinical research showing high safety profile
No tolerance, dependency, or withdrawal unlike benzodiazepines
Start with lower doses (100-200mcg) to assess individual response
Cycle usage with 1-2 week breaks to prevent potential tolerance
Not FDA-approved; approved for clinical use in Russia since early 2000s
Not recommended during pregnancy or breastfeeding due to lack of safety data
Consult healthcare provider before use, especially with other psychiatric medications","Selank rapidly elevated Brain-Derived Neurotrophic Factor (BDNF) expression in rat hippocampus, confirming involvement of neurotrophin mechanisms in its cognitive and anxiolytic effects.
Selank enhanced anxiolytic effects of diazepam while reducing undesirable side effects including memory impairment, sedation, and attention deficits. Demonstrated potential for combination therapy.
Research demonstrated that Selank affects expression of genes involved in GABAergic neurotransmission, explaining its anxiolytic mechanism comparable to benzodiazepines but without dependency risk.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Oral,https://pep-pedia.org/peptides/adalank,Adalank,N-Acetyl Selank Amidate | Enhanced Tuftsin Analog,600-900mcg,Oral,2-4 weeks,2-8°C,200-300 mcg per dose,2-3x daily,,,"Hours for anxiety relief, days to weeks for cognitive benefits","Fridge 2-8°C, use within 14-30 days",2-4 weeks (14 days in clinical trials),1-3 weeks minimum between cycles,"Adalank (N-Acetyl Selank Amidate) is an enhanced synthetic derivative of Selank peptide, featuring N-terminal acetylation and C-terminal amidation for superior stability and blood-brain barrier penetration. Developed from the immunomodulatory peptide tuftsin, it's researched for anxiety reduction, cognitive enhancement, neuroprotection, and stress resilience with improved pharmacokinetic properties compared to the parent compound.
Convenient nasal spray administration, rapid onset through nasal mucosa absorption, effective anxiety relief, cognitive enhancement, and stress management. Clinical research with parent compound Selank demonstrates strong efficacy via intranasal route.
Intranasal Adalank absorbs through nasal mucosa and crosses the blood-brain barrier to reach the central nervous system. N-acetylation and C-terminal amidation enhance stability and BBB penetration. Modulates GABAergic transmission, upregulates BDNF, and influences serotonin metabolism for anxiolytic and nootropic effects.","Weight
792.93 Da (N-Acetyl form)
Length
7 amino acids (with modifications)
Type
Modified heptapeptide (enhanced tuftsin analog)
Amino Acid Sequence:
Ac-Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH2 (N-Acetylated and C-terminal amidated)
* N-terminal acetylation and C-terminal amidation for enhanced stability, metabolic resistance, and blood-brain barrier penetration","Generalized Anxiety Disorder
Clinical trials with intranasal Selank at 2700 mcg/day for 14 days demonstrated anxiolytic efficacy comparable to benzodiazepines in GAD patients without sedation or dependency.
Rapid Anxiety Relief
Research shows 40% of patients experience rapid response with significant symptom reduction within 1-3 days of intranasal administration.
Sustained Anxiolytic Effects
Anxiolytic effects last for approximately one week after final administration, suggesting sustained neurochemical modulation.","Nootropic Enhancement
Intranasal administration provides psychostimulant and cognitive-enhancing effects alongside anxiety reduction, improving mental clarity and focus.
Memory and Attention
Clinical studies demonstrate improvements in memory, attention, and cognitive performance with intranasal Selank administration.
Antiasthenic Effects
Reduces asthenia (weakness/fatigue) and improves mental energy and motivation beyond standard anxiolytics.",,"Clinical trials with intranasal Selank at 2700 mcg/day for 14 days demonstrated anxiolytic efficacy comparable to benzodiazepines in GAD patients without sedation or dependency.
Research shows 40% of patients experience rapid response with significant symptom reduction within 1-3 days of intranasal administration.
Anxiolytic effects last for approximately one week after final administration, suggesting sustained neurochemical modulation.
Intranasal administration provides psychostimulant and cognitive-enhancing effects alongside anxiety reduction, improving mental clarity and focus.
Clinical studies demonstrate improvements in memory, attention, and cognitive performance with intranasal Selank administration.
Reduces asthenia (weakness/fatigue) and improves mental energy and motivation beyond standard anxiolytics.","Disclaimer: These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing: Intranasal Adalank is most effective when administered 2-3 times daily at regular intervals. Based on Russian clinical protocols: morning upon waking, midday, and optionally early afternoon. Consistent timing optimizes anxiolytic and cognitive benefits. Avoid doses after 4-5 PM if sensitive to stimulatory effects.",Adalank is an enhanced derivative of Selank with improved stability and longer half-life,"Both are Russian nootropic peptides with different mechanisms - Semax for cognitive enhancement, Adalank for anxiety","Different mechanisms - Adalank targets neurological/anxiety pathways, BPC-157 focuses on tissue repair",Parent compound Selank enhances benzodiazepine effects while reducing side effects in research studies,"Important: Always use bacteriostatic water (BAC). Sterile technique is essential.
Use pre-formulated nasal spray for convenience and consistency (recommended)
If reconstituting: Calculate BAC water volume for desired concentration
Mix gently and transfer to sterile nasal spray bottle
Prime nasal spray pump by pumping 3-4 times away from face
Administer 2-3 sprays (200-300mcg) per nostril as directed
Store nasal spray in refrigerator at 2-8°C between uses
Use within 14-30 days after reconstitution for optimal potency","Nasal spray should be properly sealed with tamper-evident cap, clear labeling with dosage per spray, batch number, and expiration date.
Liquid should be crystal clear and colorless with no particles, cloudiness, or discoloration. Should dispense as fine mist.
Professional pharmaceutical packaging with storage instructions, dosing guidelines, and reputable supplier information.
Small air bubbles in solution are normal and harmless. Prime pump by spraying 3-4 times away from face before first use.
Any cloudiness, yellowing, or discoloration indicates degradation or contamination. Solution should remain crystal clear.
Cracked bottle, broken spray mechanism, or signs of leakage indicate compromised product. Do not use if seal is broken before purchase.","Hours 1-6: Initial anxiety reduction and improved mental clarity
Days 1-3: Rapid responders (40%) experience significant anxiety relief
Week 1-2: Gradual responders (60%) achieve full anxiolytic effects
Week 2-4: Enhanced cognitive function, improved stress resilience, mood elevation
Post-treatment: Anxiolytic effects persist for approximately one week after final dose","CRITICAL: This is an experimental peptide with limited direct research on N-Acetyl form
Parent compound Selank has extensive Russian clinical validation via intranasal route
Approved for clinical use in Russia since early 2000s, not FDA-approved in US
Generally well-tolerated with minimal side effects in clinical trials
No tolerance, dependency, or withdrawal unlike benzodiazepines
May cause mild nasal or throat irritation (most common side effect)
Cycle with 1-3 week breaks as per Russian clinical protocols
Not recommended during pregnancy or breastfeeding due to lack of safety data
Consult healthcare provider before use, especially with psychiatric medications","Selank rapidly elevated Brain-Derived Neurotrophic Factor (BDNF) expression in rat hippocampus, confirming involvement of neurotrophin mechanisms in its cognitive and anxiolytic effects.
Selank enhanced anxiolytic effects of diazepam while reducing undesirable side effects including memory impairment, sedation, and attention deficits. Demonstrated potential for combination therapy.
Research demonstrated that Selank affects expression of genes involved in GABAergic neurotransmission, explaining its anxiolytic mechanism comparable to benzodiazepines but without dependency risk.",N/A - Intranasal spray administration,"Morning, midday, and optionally afternoon at regular intervals","Mood Enhancement
Intranasal administration elevates mood and reduces depressive symptoms through serotonin metabolism modulation and BDNF upregulation.
Stress Resilience
Enhances resilience to chronic stress and improves quality of life in patients with anxiety-asthenic disorders.
Emotional Stability
Provides balanced emotional state without sedation, maintaining normal cognitive function and responsiveness.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Injectable,https://pep-pedia.org/peptides/adamax,Adamax,Next-Generation Semax Derivative | Nootropic Neuropeptide,200-300mcg,Injectable,2-4 weeks,2-8°C,200-300 mcg,1x daily,"Belly, thigh, upper arm (subcutaneous)",Morning preferred for cognitive benefits,"Hours for acute effects, 2-4 weeks for neuroplasticity","Fridge 2-8°C, use within 14-30 days",2-4 weeks,2-4 weeks to prevent tolerance,"Adamax is a synthetic nootropic peptide and enhanced derivative of Semax, featuring N-terminal acetylation and C-terminal adamantane modification for superior stability and blood-brain barrier penetration. It's researched for cognitive enhancement, neuroprotection, neuroplasticity, and potential therapeutic applications in stroke recovery and mood disorders.
Enhanced cognitive function, improved focus and mental clarity, neuroprotection, neuroplasticity support, potential mood enhancement, and stress resilience. Superior bioavailability through direct systemic delivery.
Adamax crosses the blood-brain barrier via enhanced lipophilicity from adamantane modification. It upregulates BDNF and TrkB receptor sensitivity, modulates dopamine, norepinephrine, and serotonin levels, stabilizes microtubules through ADNP-derived mechanisms, and provides antioxidant and anti-inflammatory neuroprotection.","Weight
1,032.24 Da
Length
9 amino acids (with modifications)
Type
Modified heptapeptide derivative
Amino Acid Sequence:
Ac-Met-Glu-His-Phe-Pro-Gly-Pro-AGly-NH2
* N-terminal acetylation and C-terminal adamantane group for enhanced stability and BBB penetration",,,,"Anecdotal reports and preliminary research suggest improvements in focus, mental clarity, memory consolidation, and ability to handle complex cognitive tasks without overwhelm.
BDNF upregulation and TrkB receptor enhancement promote formation of new neural connections, synaptic plasticity, and long-term cognitive improvements through structural brain changes.
Based on parent compound research, Adamax may enhance memory formation, information retention, and learning efficiency through hippocampal BDNF-TrkB pathway activation.","Disclaimer: These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing: Injectable Adamax is most effective when administered in the morning to align with natural circadian rhythms and maximize cognitive benefits throughout the day. Consistent daily timing optimizes neuroplasticity effects. Avoid evening administration if sensitive to stimulatory effects.",,,"Different mechanisms - Adamax targets neurological function, BPC-157 focuses on tissue repair",,"Important: Always use bacteriostatic water (BAC). Sterile technique is essential.
Clean work area and hands thoroughly with alcohol
Calculate required BAC water volume using calculator below
Draw calculated BAC water into syringe
Inject slowly down vial side (not directly onto powder)
Gently swirl until completely dissolved (never shake vigorously)
Store reconstituted solution in refrigerator at 2-8°C
Use within 14-30 days for optimal potency","Lyophilized Adamax should appear as white to off-white, fluffy powder filling the vial bottom. Indicates proper freeze-drying and storage.
When properly mixed with BAC water, solution should be crystal clear with no particles, cloudiness, or discoloration.
Vial should have clear labeling with peptide name, batch number, manufacturing date, and storage instructions from reputable research supplier.
Minor compaction from shipping is acceptable if powder dissolves completely with gentle swirling. Should not remain permanently clumped.
Any yellow, brown, or unusual coloration indicates oxidation, degradation, or improper storage. Adamax should be white to off-white only.
Persistent cloudiness, particles, or precipitates after gentle mixing indicate degraded, contaminated, or improperly manufactured peptide.","Hours 1-4: Potential acute cognitive enhancement and improved focus
Week 1-2: Enhanced mental clarity, reduced anxiety, improved mood
Week 2-4: Neuroplasticity benefits, sustained cognitive improvements
Week 4+: Maximum neuroprotective and structural brain benefits
Note: Effects highly individual and based primarily on anecdotal reports","Use sterile injection technique to prevent infection
CRITICAL: This is an experimental peptide with limited human research data
Start with lower doses (100-200mcg) to assess individual response
Monitor for cardiovascular effects (increased blood pressure, heart palpitations)
Cycle usage with breaks to prevent potential tolerance development
Not recommended during pregnancy or breastfeeding
Consult healthcare provider before use, especially with cardiovascular conditions
All reported benefits are primarily anecdotal and individual","Preliminary clinical observations indicate patients treated with Adamax shortly after stroke had better neurological outcomes compared to control groups, potentially through reduction of oxidative stress and neuronal repair mechanisms.
Research demonstrates Adamax increases Brain-Derived Neurotrophic Factor (BDNF) levels and enhances TrkB receptor sensitivity in the hippocampus, fundamental mechanisms for neuroplasticity and cognitive enhancement.
Research indicates Adamax influences levels of dopamine, norepinephrine, and serotonin, contributing to improved mood, reduced anxiety, and enhanced cognitive function through balanced neurotransmitter activity.",,,"Mood Enhancement
Influences serotonin and dopamine levels to elevate mood, reduce depressive symptoms, and improve emotional resilience based on neurotransmitter modulation mechanisms.
Anxiety Reduction
Anecdotal reports indicate reduced feelings of overwhelm and anxiety, potentially through balanced neurotransmitter activity and stress hormone regulation via HPA axis modulation.
Stress Resilience
Interactions with ACTH pathways may help regulate stress hormones, improving stress response, mood stability, and overall emotional well-being.","Cognitive Enhancement
Anecdotal reports and preliminary research suggest improvements in focus, mental clarity, memory consolidation, and ability to handle complex cognitive tasks without overwhelm.
Neuroplasticity Support
BDNF upregulation and TrkB receptor enhancement promote formation of new neural connections, synaptic plasticity, and long-term cognitive improvements through structural brain changes.
Learning and Memory
Based on parent compound research, Adamax may enhance memory formation, information retention, and learning efficiency through hippocampal BDNF-TrkB pathway activation.","Stroke Recovery
Preliminary clinical observations indicate improved neurological outcomes when administered shortly after stroke, potentially through oxidative stress reduction and neuronal repair mechanisms.
Oxidative Stress Protection
Demonstrates antioxidant properties that protect neurons from oxidative damage, inflammation-induced injury, and age-related cognitive decline.
Neuronal Maintenance
Supports neuronal survival, growth, and maintenance through BDNF enhancement and microtubule stabilization, potentially protecting against neurodegenerative processes.",Adamax is an enhanced derivative of Semax with improved stability and bioavailability,"Adamax incorporates adamantyl portion from P21, may complement cognitive benefits","Both enhance cognition through different primary mechanisms (Adamax: melanocortin/BDNF, Noopept: glutamate receptors/NGF) but share BDNF upregulation. May have additive benefits - start with lower doses and monitor for overstimulation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Oral,https://pep-pedia.org/peptides/adamax,Adamax,Next-Generation Semax Derivative | Nootropic Neuropeptide,100-200mg,Oral,2-4 weeks,Room temp,100-200 mg,1-2x daily,,,"1-4 hours for acute effects, 2-4 weeks for sustained benefits","Room temp, cool dry place",2-4 weeks,2-4 weeks to prevent tolerance,"Adamax is a synthetic nootropic peptide and enhanced derivative of Semax, featuring N-terminal acetylation and C-terminal adamantane modification for superior stability and blood-brain barrier penetration. It's researched for cognitive enhancement, neuroprotection, neuroplasticity, and potential therapeutic applications in stroke recovery and mood disorders.
Convenient administration, no injection required, potentially smoother cognitive effects with less stimulation compared to parent compound. Suitable for those seeking cognitive enhancement without injectable administration.
Oral Adamax, when formulated with absorption enhancers or taken sublingually, may provide systemic cognitive benefits. The adamantane modification enhances lipid solubility and stability, though oral bioavailability remains lower than injectable routes. Effects primarily mediated through BDNF upregulation and neurotransmitter modulation after absorption.","Weight
1,032.24 Da
Length
9 amino acids (with modifications)
Type
Modified heptapeptide derivative
Amino Acid Sequence:
Ac-Met-Glu-His-Phe-Pro-Gly-Pro-AGly-NH2
* N-terminal acetylation and C-terminal adamantane group for enhanced stability and BBB penetration",,,"General Neuroprotection
Oral Adamax may provide systemic neuroprotective benefits through circulation, though concentration in brain tissue may be lower than injectable routes.
Cognitive Preservation
Long-term oral use may support cognitive preservation and neuronal health through sustained BDNF enhancement.
Antioxidant Support
Systemic antioxidant effects may provide general neuroprotection against oxidative stress and inflammation.","Anecdotal reports suggest oral Adamax provides enhanced focus, mental clarity, and ability to handle complex tasks, potentially with smoother effects than injectable administration.
May support memory formation and retention through systemic BDNF enhancement, though effects may be less pronounced than injectable route.
Users report improvements in cognitive performance, sustained attention, and mental endurance with oral administration.
Oral administration may support mood elevation and emotional well-being through neurotransmitter modulation, particularly serotonin and dopamine.
Anecdotal reports indicate reduced feelings of stress and overwhelm, potentially through HPA axis modulation and balanced stress hormone levels.
Some users report calmer mental state and reduced anxiety, though individual responses vary significantly.
Oral Adamax may provide systemic neuroprotective benefits through circulation, though concentration in brain tissue may be lower than injectable routes.
Long-term oral use may support cognitive preservation and neuronal health through sustained BDNF enhancement.
Systemic antioxidant effects may provide general neuroprotection against oxidative stress and inflammation.","Disclaimer: These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing: Oral Adamax is most effective when taken in the morning on an empty stomach or 30 minutes before meals. Sublingual administration may provide faster onset. Avoid evening doses if you experience stimulatory effects. Consistent daily timing optimizes cognitive benefits.",,,"Different mechanisms - Adamax targets neurological function, BPC-157 focuses on tissue repair",,"Important: Always use bacteriostatic water (BAC). Sterile technique is essential.
Use pre-formulated oral capsules or nasal spray (recommended for convenience and consistency)
If using powder: measure accurate dose with precision milligram scale
For sublingual: place powder or spray under tongue, hold 60-90 seconds before swallowing
For oral capsules: take with water on empty stomach or as directed
Consistent timing (morning preferred) for optimal effects
Store capsules or powder in cool, dry place at room temperature","Capsules should be intact with no cracks or moisture damage. Nasal spray should be properly sealed with clear labeling and expiration date.
Professional packaging with clear batch numbers, manufacturing dates, and storage instructions from reputable research supplier.
If using powder form, should appear as fine, white to off-white powder with no clumping, discoloration, or unusual odor.
Powder may settle in capsules or container during shipping. Gentle mixing or rotation should redistribute evenly.
Capsules should not be sticky, discolored, or show signs of moisture exposure. Powder should not be clumped or wet.
Any yellow, brown, or unusual coloration indicates degradation. Adamax should be white to off-white only.","Hours 1-4: Acute cognitive enhancement, improved focus and clarity
Week 1-2: Sustained mental performance, potential mood improvements
Week 2-4: Neuroplasticity benefits, reduced anxiety and stress
Note: Oral bioavailability lower than injectable - effects may be more subtle
All effects primarily based on anecdotal reports and individual variation","CRITICAL: This is an experimental peptide with very limited human research
Start with lower doses (100mg) to assess individual tolerance
May cause headaches, insomnia, or anxiety at higher doses
Monitor for cardiovascular effects (blood pressure, heart palpitations)
Take breaks every 2-4 weeks to prevent potential tolerance
Not recommended during pregnancy or breastfeeding
Consult healthcare provider before use","Preliminary clinical observations indicate patients treated with Adamax shortly after stroke had better neurological outcomes compared to control groups, potentially through reduction of oxidative stress and neuronal repair mechanisms.
Research demonstrates Adamax increases Brain-Derived Neurotrophic Factor (BDNF) levels and enhances TrkB receptor sensitivity in the hippocampus, fundamental mechanisms for neuroplasticity and cognitive enhancement.
Research indicates Adamax influences levels of dopamine, norepinephrine, and serotonin, contributing to improved mood, reduced anxiety, and enhanced cognitive function through balanced neurotransmitter activity.",N/A - Oral/Sublingual administration,"Morning preferred, avoid evening if stimulatory",,"Focus and Mental Clarity
Anecdotal reports suggest oral Adamax provides enhanced focus, mental clarity, and ability to handle complex tasks, potentially with smoother effects than injectable administration.
Memory Support
May support memory formation and retention through systemic BDNF enhancement, though effects may be less pronounced than injectable route.
Cognitive Performance
Users report improvements in cognitive performance, sustained attention, and mental endurance with oral administration.",,Adamax is an enhanced derivative of Semax with improved stability and bioavailability,"Adamax incorporates adamantyl portion from P21, may complement cognitive benefits","Both enhance cognition through different primary mechanisms (Adamax: melanocortin/BDNF, Noopept: glutamate receptors/NGF) but share BDNF upregulation. May have additive benefits - start with lower doses and monitor for overstimulation.","Mood Enhancement
Oral administration may support mood elevation and emotional well-being through neurotransmitter modulation, particularly serotonin and dopamine.
Stress Management
Anecdotal reports indicate reduced feelings of stress and overwhelm, potentially through HPA axis modulation and balanced stress hormone levels.
Anxiety Reduction
Some users report calmer mental state and reduced anxiety, though individual responses vary significantly.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Injectable,https://pep-pedia.org/peptides/adipotide,Adipotide (Prohibitin‑TP01),Prohibitin‑Targeting Peptidomimetic | Experimental Anti‑Obesity,0.43 mg/kg,Injectable,28 days,2–8°C (reconstituted),0.43 mg/kg,Once daily,Rotated abdominal SubQ sites,Consistent daily timing; monitor hydration,Fat loss visible by 2–4 weeks in primate models,2–8°C,28 days,≥4 weeks,"Adipotide (Prohibitin‑TP01) is a chimeric, adipose‑vasculature–targeted peptidomimetic that homes to prohibitin/annexin A2 on white adipose tissue endothelium and delivers a pro‑apoptotic D‑(KLAKLAK)2 motif. In obese primates it produced rapid fat loss with improved insulin resistance, but development halted after an early Phase 1 oncology trial; kidney safety signals (reversible proximal tubule changes) remain a key concern.
Rapid fat‑mass reduction in obese non‑human primates with improved insulin sensitivity; direct WAT vascular targeting.
CKGGRAKDC homes to prohibitin/annexin A2 on white‑fat endothelium; the linked D‑(KLAKLAK)2 disrupts mitochondrial membranes after internalization, triggering localized endothelial apoptosis and adipocyte loss.",,,,,Selective WAT vascular targeting produced 7–15% body‑weight loss over 4 weeks in obese macaques.,"Disclaimer: These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing: Rotate SC sites to reduce irritation; ensure adequate hydration and frequent renal labs during treatment.",,,,,"Important: Always use bacteriostatic water (BAC). Sterile technique is essential.
Sanitize hands and workspace; swab vial septum.
Inject BAC water slowly down the vial wall; do not jet onto powder.
Gently swirl until fully dissolved (do not shake).
Label with concentration/date; store at 2–8°C; discard per lab SOP.","White, uniform ‘cake’ indicates proper lyophilization.
Fully dissolved, particle‑free solution after reconstitution.
Small clumps may form from shipping; should fully dissolve with gentle swirl.
Suggests temperature excursion; do not use without QC.
Indicates degradation or contamination—discard per SOP.","Week 1–2: Early reduction in abdominal circumference
Week 2–4: Progressive weight/fat‑mass decline
Recovery: Partial rebound possible after discontinuation
Common lab signals: mild creatinine rise, electrolyte shifts","Not FDA‑approved; investigational/educational only.
Monitor serum creatinine, BUN, urinalysis, electrolytes weekly in animal studies.
Kidney: dose‑dependent, largely reversible proximal tubule changes observed in primates.
Avoid dehydration; consider temporarily pausing if creatinine rises persistently.
Pregnancy/lactation: not studied; avoid.","Molecular MRI using CKGGRAKDC confirmed prohibitin‑based adipose targeting, supporting the translational targeting concept.
White‑adipose vasculature targeting led to rapid fat mass reduction and improved insulin dynamics. Kidney signals (creatinine rise, tubular changes) were dose‑related and largely reversible after discontinuation.
Identified 0.43 mg/kg SC daily as the optimal primate dose balancing efficacy and renal safety for subsequent fixed‑dose testing.",,,,,,,,,,"Adipose Mass Reduction
Selective WAT vascular targeting produced 7–15% body‑weight loss over 4 weeks in obese macaques.","Insulin Resistance
Improved insulin response (reduced insulin AUC) following fat‑mass reduction in primates.","Non‑CNS Mechanism
Weight loss without primary appetite suppression; peripheral (vascular) mechanism.",Potential additive dehydration/GI effects; monitor renal function (adipotide has dose‑related proximal tubule effects).,"Overlapping weight‑loss effects; monitor kidney function, volume status, and electrolytes.",No clinical data on co‑administration; mechanisms differ (satiety vs. adipose vasculature).,No published data on combined use or pharmacodynamic interaction.,No known direct interaction; distinct mechanisms and targets.,Metabolic effects may confound body‑composition endpoints; consider staging or separating protocols.,"Theoretical vascular/pressor effects; if studied together, stagger dosing and monitor BP and hydration.",Adipotide shows dose‑dependent proximal tubule injury in primates; avoid additional renal insults.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Topical,https://pep-pedia.org/peptides/ahk-cu,AHK-Cu (Copper Tripeptide-3),Hair Growth Copper Peptide | Dermal Papilla Stimulator,0.3-1% concentration,Topical,12-24 weeks minimum,2-8°C (refrigerated),0.5-1% concentration applied to scalp or skin,Once or twice daily,,,Week 2-4: Reduced shedding may begin; Month 2-3: New growth visible; Month 4-6: Significant improvement; 6-12 months: Full results,Refrigerate at 2-8°C; protect from light; use reconstituted solutions within 30 days,Minimum 12-24 weeks for hair growth assessment; can be used continuously,Not typically cycled; continuous use for best results,"AHK-Cu (Copper Tripeptide-3) is a synthetic copper-binding tripeptide composed of Alanine-Histidine-Lysine complexed with a copper ion (Cu²⁺). While structurally similar to the naturally occurring GHK-Cu (differing only in the first amino acid - alanine vs glycine), AHK-Cu demonstrates targeted activity on dermal papilla cells and hair follicles. Research shows it stimulates hair follicle elongation, promotes dermal papilla cell proliferation, increases VEGF production, and inhibits TGF-β1 - making it particularly promising for hair growth applications. It also supports skin regeneration through fibroblast activation and collagen synthesis.
Stimulates hair follicle elongation, promotes dermal papilla cell proliferation, increases VEGF for improved scalp circulation, reduces TGF-β1 (counters DHT effects), anti-apoptotic protection for follicles, collagen synthesis support, convenient topical application
AHK-Cu penetrates the scalp to deliver copper directly to dermal papilla cells and hair follicles. It activates proliferation pathways, elevates the Bcl-2/Bax ratio (anti-apoptotic), increases VEGF production for enhanced blood flow, reduces TGF-β1 secretion, and promotes SOD production to reduce oxidative stress. These combined effects support the anagen (growth) phase and may help revive miniaturized follicles.","Weight
416.9 Da
Length
3 amino acids
Type
Copper tripeptide complex
Amino Acid Sequence:
L-Alanyl-L-Histidyl-L-Lysine (Ala-His-Lys)
* Complexed with divalent copper ion (Cu²⁺). Synthetic analog of GHK-Cu with alanine replacing glycine at N-terminus. Molecular formula: C15H24CuN6O4",,,,"Ex vivo studies demonstrate AHK-Cu stimulates human hair follicle elongation at concentrations as low as 10⁻¹² M, promoting longer anagen phase
Increases proliferation of dermal papilla cells, the key regulatory cells for hair follicle cycling and hair growth
Boosts vascular endothelial growth factor production, improving blood flow and nutrient delivery to hair follicles
Reduces TGF-β1 secretion and oxidative stress (via SOD), both of which contribute to DHT-induced follicle miniaturization","Disclaimer: These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing: Apply to clean, dry scalp or skin. Evening application is preferred to avoid UV exposure which can degrade the peptide. If using other actives, apply AHK-Cu first and allow to absorb before layering.",,,Different tissue repair mechanisms - BPC-157 promotes systemic healing while AHK-Cu targets skin/hair. Safe to use in parallel for comprehensive regeneration support,,"Important: Always use bacteriostatic water (BAC). Sterile technique is essential.
Calculate amount needed for desired concentration (e.g., 100mg for 1% in 10mL)
Dissolve AHK-Cu powder in distilled water or water phase of formulation
Verify pH is between 5.5-7.0 - adjust if necessary (avoid pH below 5)
Add to cool-down phase of formulation (<40°C / 104°F) - heat degrades peptide
Mix gently until fully incorporated - do not shake vigorously
Transfer to dark glass container to protect from light
Store refrigerated at 2-8°C
Use within 30 days of preparation","AHK-Cu powder should have a characteristic light blue color from the copper complex
Pharmaceutical/cosmetic grade with certificate of analysis confirming identity and purity
Should dissolve to clear light blue solution; cloudiness indicates quality issues
Final product pH between 5.5-7.0 for optimal stability and skin compatibility
Liposomal delivery systems improve AHK-Cu stability and skin/scalp penetration
Brown, green, or colorless solutions indicate degradation - do not use
Acidic conditions destabilize copper peptide complex - verify pH before use","Week 1-2: No visible changes; peptide is working at cellular level
Week 2-4: Some users report reduced hair shedding; scalp may feel healthier
Month 1-2: Vellus (fine) hairs may begin appearing in thinning areas
Month 2-3: New growth becoming visible; existing hairs may appear thicker
Month 3-4: Noticeable improvement in hair density and quality
Month 4-6: Significant results visible; continued improvement expected
Month 6-12: Full results achieved with consistent use
For skin: Improvements in texture and firmness may be noticed within 4-8 weeks","Generally well-tolerated with excellent safety profile in topical applications
Avoid use with acidic products (AHAs, BHAs, Vitamin C) - use at different times
Do not combine with additional copper supplements - risk of copper toxicity
Keep pH between 5.5-7.0 for stability and skin compatibility
Store properly - degrades with heat, light, and improper pH
Patch test before full application if sensitive skin
Discontinue if irritation, redness, or itching persists
Not for use on broken or infected skin
Avoid eye area - may cause irritation
Limited long-term safety data - use as directed","Novel delivery system using thermodynamically stable ionic liquid microemulsions to improve topical delivery and stability of copper tripeptides including AHK-Cu for enhanced therapeutic effects.
While focused on GHK-Cu, this landmark review establishes the broader mechanisms of copper tripeptides in tissue regeneration, collagen synthesis, and anti-inflammatory pathways relevant to AHK-Cu.
Evaluated transdermal delivery of copper tripeptide, demonstrating penetration through skin layers with potential for topical therapeutic applications in skin regeneration and hair growth.",,Evening application preferred to avoid UV exposure; can use AM if no sun exposure,,,,,,,,,,,,,,,,,,,"Scalp (thinning areas), face, areas needing regeneration","Hair Follicle Elongation
Ex vivo studies demonstrate AHK-Cu stimulates human hair follicle elongation at concentrations as low as 10⁻¹² M, promoting longer anagen phase
Dermal Papilla Cell Proliferation
Increases proliferation of dermal papilla cells, the key regulatory cells for hair follicle cycling and hair growth
VEGF Upregulation
Boosts vascular endothelial growth factor production, improving blood flow and nutrient delivery to hair follicles
Anti-DHT Mechanism
Reduces TGF-β1 secretion and oxidative stress (via SOD), both of which contribute to DHT-induced follicle miniaturization","Fibroblast Stimulation
Activates fibroblast proliferation and collagen synthesis for improved skin structure and wound healing
Anti-Apoptotic Effects
Elevates Bcl-2/Bax ratio and reduces caspase-3 activation, protecting cells from programmed death
Extracellular Matrix Support
Promotes deposition of collagen and other ECM components for tissue renewal and repair",Complementary copper peptides targeting different aspects of tissue regeneration. GHK-Cu excels at skin repair while AHK-Cu targets hair follicles. Can be combined in formulations,"Both promote hair growth via different mechanisms - minoxidil via potassium channel opening and vasodilation, AHK-Cu via dermal papilla stimulation and VEGF. Often combined in hair loss protocols",5-alpha reductase inhibitors block DHT production while AHK-Cu may help counter DHT effects on follicles. Different mechanisms support combination approach,Risk of copper toxicity when combined with additional copper sources. Monitor total copper intake and avoid stacking copper peptides with oral copper supplements,"Low pH of ascorbic acid can destabilize copper peptides. Use at different times - Vitamin C in morning, AHK-Cu in evening - to avoid interaction","Acidic exfoliants (glycolic, salicylic acid) can destabilize copper peptide complexes and reduce effectiveness. Use at different times or in separate routines",Both are potent actives that can cause irritation. Retinoids also lower skin pH. Introduce slowly or use at different times to avoid sensitization,May interfere with copper binding and reduce peptide effectiveness. Monitor for reduced efficacy if using iron-chelating compounds,Excellent combination - hyaluronic acid provides hydration and supports peptide penetration while AHK-Cu promotes follicle and skin health,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Injectable,https://pep-pedia.org/peptides/ahk-cu,AHK-Cu (Copper Tripeptide-3),Hair Growth Copper Peptide | Dermal Papilla Stimulator,Research pending,Injectable,Limited data,2-8°C,Not well established - consult practitioner,Varies by protocol,"Mesotherapy: scalp, face. SubQ: abdominal fat",No established optimal timing,Limited data on injectable timeline,Refrigerate at 2-8°C after reconstitution,Not established,Not established,"AHK-Cu (Copper Tripeptide-3) is a synthetic copper-binding tripeptide composed of Alanine-Histidine-Lysine complexed with a copper ion (Cu²⁺). While structurally similar to the naturally occurring GHK-Cu (differing only in the first amino acid - alanine vs glycine), AHK-Cu demonstrates targeted activity on dermal papilla cells and hair follicles. Research shows it stimulates hair follicle elongation, promotes dermal papilla cell proliferation, increases VEGF production, and inhibits TGF-β1 - making it particularly promising for hair growth applications. It also supports skin regeneration through fibroblast activation and collagen synthesis.
Direct delivery bypassing skin barrier, potentially higher bioavailability, systemic effects possible
Injectable administration delivers AHK-Cu directly to target tissues, potentially offering more consistent dosing than topical application. However, research on injectable AHK-Cu specifically is limited compared to topical use.","Weight
416.9 Da
Length
3 amino acids
Type
Copper tripeptide complex
Amino Acid Sequence:
L-Alanyl-L-Histidyl-L-Lysine (Ala-His-Lys)
* Complexed with divalent copper ion (Cu²⁺). Synthetic analog of GHK-Cu with alanine replacing glycine at N-terminus. Molecular formula: C15H24CuN6O4",,,,,Disclaimer: These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.,,,Different tissue repair mechanisms - BPC-157 promotes systemic healing while AHK-Cu targets skin/hair. Safe to use in parallel for comprehensive regeneration support,,"Important: Always use bacteriostatic water (BAC). Sterile technique is essential.
Use only pharmaceutical-grade AHK-Cu for injection
Reconstitute with bacteriostatic water to desired concentration
Verify solution is clear with characteristic light blue color
Filter through 0.22 μm sterile filter before use
Store refrigerated at 2-8°C
Use within 14-21 days of reconstitution","Injectable AHK-Cu protocols are less established than topical. Consult qualified practitioner
Only use pharmaceutical-grade peptide with sterility testing for injection
Never inject cosmetic-grade or research-grade peptides not intended for injection","Injectable AHK-Cu protocols are experimental
Effects may be more pronounced than topical due to direct delivery
Timeline and results are not well established
Consult with experienced practitioner for mesotherapy applications","Injectable use has limited research compared to topical
Use only pharmaceutical-grade peptide for injection
Sterile technique essential to prevent infection
Monitor for injection site reactions
Copper toxicity risk if doses are excessive
Mesotherapy should only be performed by trained practitioners
Not FDA-approved for any injectable indication","Novel delivery system using thermodynamically stable ionic liquid microemulsions to improve topical delivery and stability of copper tripeptides including AHK-Cu for enhanced therapeutic effects.
While focused on GHK-Cu, this landmark review establishes the broader mechanisms of copper tripeptides in tissue regeneration, collagen synthesis, and anti-inflammatory pathways relevant to AHK-Cu.
Evaluated transdermal delivery of copper tripeptide, demonstrating penetration through skin layers with potential for topical therapeutic applications in skin regeneration and hair growth.",,,,,,,,,,,,,,,,,,,,,,,,Complementary copper peptides targeting different aspects of tissue regeneration. GHK-Cu excels at skin repair while AHK-Cu targets hair follicles. Can be combined in formulations,"Both promote hair growth via different mechanisms - minoxidil via potassium channel opening and vasodilation, AHK-Cu via dermal papilla stimulation and VEGF. Often combined in hair loss protocols",5-alpha reductase inhibitors block DHT production while AHK-Cu may help counter DHT effects on follicles. Different mechanisms support combination approach,Risk of copper toxicity when combined with additional copper sources. Monitor total copper intake and avoid stacking copper peptides with oral copper supplements,"Low pH of ascorbic acid can destabilize copper peptides. Use at different times - Vitamin C in morning, AHK-Cu in evening - to avoid interaction","Acidic exfoliants (glycolic, salicylic acid) can destabilize copper peptide complexes and reduce effectiveness. Use at different times or in separate routines",Both are potent actives that can cause irritation. Retinoids also lower skin pH. Introduce slowly or use at different times to avoid sensitization,May interfere with copper binding and reduce peptide effectiveness. Monitor for reduced efficacy if using iron-chelating compounds,Excellent combination - hyaluronic acid provides hydration and supports peptide penetration while AHK-Cu promotes follicle and skin health,"Limited Injectable Research
Most AHK-Cu research focuses on topical application for hair and skin. Injectable protocols are less established than for GHK-Cu
Mesotherapy Applications
Some practitioners use copper peptides in mesotherapy (microinjections) for scalp and facial rejuvenation, but standardized protocols are lacking
Extrapolated from GHK-Cu Data
Injectable dosing is often extrapolated from GHK-Cu research, which has more established injectable protocols",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Injectable,https://pep-pedia.org/peptides/aod-9604,AOD-9604,Advanced Obesity Drug | Modified hGH Fragment 176-191,250-500mcg,Injectable,8-12 weeks,2-8°C,250-500mcg,"Once daily, morning preferred","Subcutaneous: abdomen (near belly button), thigh","Morning on empty stomach, 30 min before food",Fat loss effects typically observed 4-8 weeks,"Lyophilized: room temp short-term, freezer long-term. Reconstituted: 2-8°C for 28 days",8-12 weeks,4 weeks between cycles,"AOD-9604 is a modified 17-amino acid fragment of human growth hormone (hGH 176-191) with an added N-terminal tyrosine. It stimulates lipolysis and inhibits lipogenesis without the growth-promoting effects of full hGH. Unlike intact growth hormone, AOD-9604 does not increase IGF-1, affect glucose metabolism, or bind to the GH receptor.
Stimulates fat loss through lipolysis without growth hormone side effects. Does not increase IGF-1, affect glucose metabolism, or cause insulin resistance. Also shows promise for cartilage repair.
AOD-9604 stimulates lipolysis and inhibits lipogenesis through beta-3 adrenergic receptor upregulation, without binding to the GH receptor. This selective action provides fat-burning effects without the hyperglycemia, insulin resistance, or cell proliferation associated with full growth hormone.","Weight
1,815.1 Da
Length
17 amino acids
Type
Modified hGH C-terminal fragment
Amino Acid Sequence:
YLRIVQCRSVEGSCGF (Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe)
* hGH fragment 176-191 with N-terminal tyrosine addition; contains disulfide bond between Cys183 and Cys189",,,,"Primary research indication. Increases fat oxidation, plasma glycerol levels, and reduces body weight in obese models without affecting glucose metabolism.
Reduces fat synthesis and storage in adipose tissue. Effects demonstrated in both animal models and isolated human adipose tissue.
Unlike full hGH, does not cause hyperglycemia, reduce insulin secretion, or increase insulin resistance. Safer metabolic profile.","Disclaimer: These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing: Best administered in the morning on an empty stomach. Wait 30 minutes before eating. Some research protocols suggest injection into abdominal subcutaneous fat for localized effect.",,,Different mechanisms of action. Sometimes combined in regenerative protocols.,,"Important: Always use bacteriostatic water (BAC). Sterile technique is essential.
Allow vial to reach room temperature (15-20 minutes)
Calculate required BAC water volume using calculator below
Draw BAC water into syringe
Inject slowly down vial side (not directly onto powder)
Gently swirl until dissolved (never shake vigorously)
Store reconstituted solution at 2-8°C and use within 28 days","Should appear as white to off-white powder or cake. Uniform appearance indicates proper freeze-drying.
When mixed with BAC water, solution should be crystal clear without particles or cloudiness.
Quality suppliers provide CoA showing purity >98% by HPLC and confirmed amino acid sequence.
AOD-9604 has GRAS status for food use but is NOT approved as a therapeutic drug. Research chemical only.
Yellow discoloration, excessive clumping, or collapsed appearance may indicate degradation.
Banned by World Anti-Doping Agency. Athletes subject to testing must not use this compound.","Week 1-2: Minimal noticeable effects, compound building in system
Week 3-4: May notice subtle changes in body composition
Week 5-8: More noticeable fat loss, especially with diet and exercise
Week 8-12: Continued fat reduction, improved body composition
Side effects: Generally well-tolerated, mild injection site reactions possible","Generally well-tolerated in clinical trials
Does not affect blood glucose or insulin - safer than full hGH
Does not increase IGF-1 levels
May cause mild injection site reactions
Not recommended during pregnancy or breastfeeding
WADA prohibited substance - not for competitive athletes","Combined AOD-9604 and hyaluronic acid injections were more effective than either alone. Lameness recovery was fastest in the combination group (11±4 days vs 25±2 days for controls). AOD-9604 enhanced cartilage regeneration without stimulating IGF-1.
Validated detection method with 50 pg/mL limit. Identified six potential metabolites. The metabolite CRSVEGSCG proved significantly more stable than the parent compound in serum. Confirmed peptide sequence structure.
Both hGH and AOD-9604 significantly reduced body weight gain in obese mice, correlated with increased in vivo fat oxidation and plasma glycerol levels. Importantly, AOD-9604 did not cause hyperglycemia or reduce insulin secretion like full hGH.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Research shows combined AOD-9604 and HA injections are more effective for cartilage repair than either alone.,,"Fat Loss / Lipolysis
Primary research indication. Increases fat oxidation, plasma glycerol levels, and reduces body weight in obese models without affecting glucose metabolism.
Lipogenesis Inhibition
Reduces fat synthesis and storage in adipose tissue. Effects demonstrated in both animal models and isolated human adipose tissue.
Metabolic Safety
Unlike full hGH, does not cause hyperglycemia, reduce insulin secretion, or increase insulin resistance. Safer metabolic profile.","Cartilage Repair
Emerging indication. Combined with hyaluronic acid, showed enhanced cartilage regeneration in osteoarthritis models.
Joint Health
Accelerated lameness recovery in animal studies. Does not stimulate IGF-1, potentially safer for joint applications.
Osteoarthritis
Research shows synergistic effects with HA for OA treatment. May support joint repair without growth-promoting risks.","AOD-9604 does not affect GH axis, allowing combination with GH secretagogues.",No known interactions. Different mechanisms - can be used together.,Different fat loss mechanisms. May have complementary effects on weight management.,AOD-9604 does not affect glucose metabolism or insulin sensitivity unlike full hGH.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Oral,https://pep-pedia.org/peptides/5-amino-1mq,5-Amino-1MQ,NNMT Inhibitor | Longevity & Metabolic Enhancement,50-100mg,Oral,8-12 weeks,Room temp,50-75mg,Once daily with food,,,"Energy: 1-2 weeks, Metabolic: 4-8 weeks, Longevity: 8-12 weeks","Cool, dry place at room temperature",8-12 weeks,2-4 weeks off between cycles,"5-Amino-1MQ is a small molecule NNMT (nicotinamide N-methyltransferase) inhibitor that enhances cellular NAD+ levels and mitochondrial function. Originally developed for metabolic research, it's gaining attention for its potential anti-aging properties and ability to improve energy metabolism at the cellular level.
Enhanced NAD+ levels, improved mitochondrial function, longevity benefits, better energy metabolism, enhanced cellular repair, improved insulin sensitivity, convenient daily dosing
Orally administered 5-Amino-1MQ inhibits NNMT enzyme systemically, preventing NAD+ degradation and maintaining higher cellular NAD+ levels throughout the body, supporting mitochondrial function and metabolic processes",,,,,"Significantly increases cellular NAD+ levels by inhibiting NNMT enzyme, supporting cellular energy production and DNA repair mechanisms essential for healthy aging
Improves mitochondrial biogenesis and efficiency, enhancing cellular energy production and reducing oxidative stress markers associated with aging
Enhanced NAD+ availability supports sirtuins and other longevity pathways involved in DNA repair, cellular maintenance, and stress resistance","Disclaimer: These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing: Take 5-Amino-1MQ with food to improve absorption and reduce potential GI effects. Consistent daily timing helps maintain steady NAD+ levels. Morning or early afternoon dosing is preferred to avoid potential sleep interference.",,,No known interactions; different mechanisms of action with potential complementary benefits,,"Important: Always use bacteriostatic water (BAC). Sterile technique is essential.
Use pre-made capsules for convenience and accuracy (recommended)
If using powder: measure precise dose with milligram scale
Take with food to improve absorption and reduce GI effects
Maintain consistent daily timing for optimal results
Store in cool, dry place away from light and moisture
Consider cycling: 8-12 weeks on, 2-4 weeks off","High-quality capsules should be uniform in color and size with clear labeling and batch information
Reputable suppliers provide COA with purity analysis (should be >98% pure) and heavy metal testing
Sealed bottles with moisture protection, clear expiration dates, and professional labeling
Capsules should not be sticky, discolored, or show signs of moisture exposure or heat damage
Should be relatively odorless; strong chemical odors may indicate contamination or degradation","Week 1-2: Gradual increase in energy levels and mental clarity
Week 2-4: Enhanced exercise performance and recovery
Week 4-8: Improved metabolic markers and body composition
Week 8-12: Sustained longevity benefits and cellular health
Side effects: Generally minimal, occasional mild GI adjustment
Most effective for: Metabolic health, longevity, energy enhancement","No human clinical trials published - all dosing extrapolated from animal studies
38.4% oral bioavailability demonstrated in rats (PubMed 34304009)
Start with lowest effective dose (25-50mg) to assess tolerance
Take with food to reduce potential GI effects
Monitor for any unusual symptoms and discontinue if adverse effects occur
Not recommended for pregnant or breastfeeding women
Consult healthcare provider before use, especially with existing conditions","40% grip strength improvement in sedentary mice, 60% with exercise. No adverse effects observed.
Demonstrated 38.4% oral bioavailability, half-life 6.9hr (oral) and 3.8hr (IV). Supports oral administration viability.
Diet-induced obese mice showed 5.1% weight loss, 30% adipocyte size reduction. Human equivalent ~5mg/kg/day using FDA allometric scaling.",N/A - Oral administration,With breakfast or lunch for better absorption,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"NAD+ Enhancement
Significantly increases cellular NAD+ levels by inhibiting NNMT enzyme, supporting cellular energy production and DNA repair mechanisms essential for healthy aging
Mitochondrial Function
Improves mitochondrial biogenesis and efficiency, enhancing cellular energy production and reducing oxidative stress markers associated with aging
Cellular Repair
Enhanced NAD+ availability supports sirtuins and other longevity pathways involved in DNA repair, cellular maintenance, and stress resistance","Energy Metabolism
Improves cellular energy production through enhanced mitochondrial function and more efficient glucose and fatty acid utilization pathways
Insulin Sensitivity
Research shows improved insulin sensitivity and glucose metabolism through enhanced cellular energy processes and mitochondrial function
Metabolic Flexibility
Enhances the body's ability to switch between fuel sources (glucose and fat) for optimal energy production and metabolic health","Metabolic Rate Enhancement
Increases basal metabolic rate and helps body burn fat for energy while maintaining muscle mass through improved mitochondrial function
Fat Oxidation
Studies show enhanced fat burning capacity and improved body composition through optimized cellular energy metabolism
Appetite Regulation
May help regulate appetite and energy balance through improved cellular signaling and metabolic efficiency",May work synergistically with NAD+ precursors by preventing breakdown while supporting production,Both support longevity pathways; resveratrol activates sirtuins while 5-Amino-1MQ provides NAD+ substrate,Both affect metabolic pathways; combination may enhance effects but requires careful monitoring,Limited interaction data; consult healthcare provider before combining with anticoagulants,Both affect metabolic pathways; potential additive effects on glucose metabolism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Injectable,https://pep-pedia.org/peptides/5-amino-1mq,5-Amino-1MQ,NNMT Inhibitor | Longevity & Metabolic Enhancement,150-600mcg or 50-100mg,Injectable,4-8 weeks,2-8°C,Varies by protocol: 150-600mcg (conservative) OR 50-100mg (common),Once daily,"SubQ: abdomen, thigh, arm",Morning or early afternoon (avoid late day),"Energy: 3-7 days, Metabolic: 1-3 weeks, Weight: 2-6 weeks","Refrigerate 2-8°C, use within 28 days",4-8 weeks,2-4 weeks off between cycles,"5-Amino-1MQ is a small molecule NNMT (nicotinamide N-methyltransferase) inhibitor that enhances cellular NAD+ levels and mitochondrial function. Originally developed for metabolic research, it's gaining attention for its potential anti-aging properties and ability to improve energy metabolism at the cellular level.
Higher bioavailability, precise dosing, rapid systemic effects, research-validated delivery method, enhanced NAD+ elevation, superior metabolic impact
Injectable 5-Amino-1MQ provides direct systemic delivery with 100% bioavailability, rapidly inhibiting NNMT enzyme and maximizing NAD+ elevation for enhanced cellular energy and metabolic benefits",,,,,"Injectable delivery provides immediate systemic effects on metabolic rate and cellular energy production with superior bioavailability
Direct systemic delivery maximizes fat burning capacity and metabolic flexibility through optimal NNMT inhibition
Injectable form shows enhanced effects on insulin sensitivity and glucose utilization compared to oral administration
Research studies using injectable 5-Amino-1MQ showed significant weight loss and body composition improvements
Direct systemic delivery provides maximum metabolic enhancement for weight management and body recomposition
Injectable form may provide enhanced appetite regulation effects through optimized metabolic signaling
Injectable delivery achieves highest NAD+ levels and most pronounced longevity pathway activation
Superior bioavailability enhances cellular repair mechanisms and stress resistance pathways
Direct systemic delivery maximizes mitochondrial biogenesis and function for longevity benefits","Disclaimer: These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing: Injectable 5-Amino-1MQ is best administered in the morning or early afternoon to avoid potential sleep interference. Rotate injection sites to prevent tissue irritation. Effects are typically faster than oral administration.",,,No known interactions; different mechanisms of action with potential complementary benefits,,"Important: Always use bacteriostatic water (BAC). Sterile technique is essential.
Confirm which protocol (mcg vs mg) you're following
Clean vial stopper, inject BAC water slowly down side
Gently swirl until dissolved (never shake)
Label clearly with concentration AND units (mg/mL)
Store in refrigerator, use within 28 days","5-10mg vials for conservative mcg dosing, 50-200mg vials for common mg dosing
5-Amino-1MQ commonly appears as orange to amber colored powder. Color consistency within batch is important
Should dissolve completely in BAC water to form clear, colorless solution with no particles
Obtained from reputable research chemical suppliers with proper documentation and purity certificates
Powder should not be clumped, sticky, or show signs of moisture exposure during storage
Persistent cloudiness or particles after reconstitution may indicate degradation or contamination","Week 1: Energy increase (variable by protocol)
Week 2-3: Metabolic changes (more pronounced with mg dosing)
Week 3-4: May feel 'winded' during cardio (adaptation phase)
Week 4-6: Body composition changes (dose-dependent)
Week 6-8: Effects plateau - cycling recommended
Conservative mcg protocol: Subtle or minimal effects reported
Common mg protocol: More pronounced effects
Most effective for: Unknown due to lack of human trials","Verify dose units - mcg vs mg is 1000x difference
Start with lower doses to assess tolerance
Use sterile injection technique to prevent infection
Not recommended for pregnant or breastfeeding women","40% grip strength improvement in sedentary mice, 60% with exercise. No adverse effects observed.
Demonstrated 38.4% oral bioavailability, half-life 6.9hr (oral) and 3.8hr (IV). Supports oral administration viability.
Diet-induced obese mice showed 5.1% weight loss, 30% adipocyte size reduction. Human equivalent ~5mg/kg/day using FDA allometric scaling.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,May work synergistically with NAD+ precursors by preventing breakdown while supporting production,Both support longevity pathways; resveratrol activates sirtuins while 5-Amino-1MQ provides NAD+ substrate,Both affect metabolic pathways; combination may enhance effects but requires careful monitoring,Limited interaction data; consult healthcare provider before combining with anticoagulants,Both affect metabolic pathways; potential additive effects on glucose metabolism,"Rapid Metabolic Enhancement
Injectable delivery provides immediate systemic effects on metabolic rate and cellular energy production with superior bioavailability
Enhanced Fat Oxidation
Direct systemic delivery maximizes fat burning capacity and metabolic flexibility through optimal NNMT inhibition
Improved Glucose Metabolism
Injectable form shows enhanced effects on insulin sensitivity and glucose utilization compared to oral administration","Accelerated Fat Loss
Research studies using injectable 5-Amino-1MQ showed significant weight loss and body composition improvements
Metabolic Rate Boost
Direct systemic delivery provides maximum metabolic enhancement for weight management and body recomposition
Appetite Suppression
Injectable form may provide enhanced appetite regulation effects through optimized metabolic signaling","Maximal NAD+ Enhancement
Injectable delivery achieves highest NAD+ levels and most pronounced longevity pathway activation
Cellular Repair Optimization
Superior bioavailability enhances cellular repair mechanisms and stress resistance pathways
Mitochondrial Optimization
Direct systemic delivery maximizes mitochondrial biogenesis and function for longevity benefits",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Oral,https://pep-pedia.org/peptides/omberacetam,Omberacetam (Noopept),Synthetic Dipeptide | Cognitive Enhancement Nootropic,10-30mg,Oral,"4-8 weeks on, 2-4 weeks off","Room temperature, protect from moisture",10-20mg per administration,"1-3 times daily, morning and early afternoon preferred",,,"Onset 20-60 minutes, peak 2 hours, duration 3-5 hours","Room temperature, protect from moisture and light",4-8 weeks continuous use recommended,2-4 weeks break between cycles to prevent tolerance,"Omberacetam (also known as Noopept or GVS-111) is a synthetic nootropic dipeptide (N-phenylacetyl-L-prolylglycine ethyl ester) developed in Russia in 1996 for its potent cognitive-enhancing and neuroprotective properties. While structurally distinct from racetams, it's considered part of the nootropic family and functions as a prodrug that converts to the active metabolite cycloprolylglycine (CPG). Research indicates it may enhance memory, learning, and neuroplasticity through BDNF/NGF upregulation and glutamatergic modulation at doses 1000x lower than piracetam.
Primary administration route, rapid oral bioavailability, convenient dosing, well-studied in clinical trials, peak absorption within 7 minutes
Rapidly absorbed orally and converted to active metabolite cycloprolylglycine (CPG) which modulates AMPA/NMDA glutamate receptors and enhances cholinergic neurotransmission",,,,,"Improved memory consolidation and retrieval through enhanced synaptic plasticity and neurotrophic factor expression
Faster acquisition of new information via AMPA receptor modulation and enhanced long-term potentiation
Sustained attention improvements through acetylcholine sensitization and glutamatergic enhancement","Disclaimer: These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing: Morning and early afternoon dosing maximizes cognitive benefits while avoiding sleep disruption",,,,,"Important: Always use bacteriostatic water (BAC). Sterile technique is essential.
Omberacetam is typically supplied as tablets (10mg), capsules, or powder form
For powder: Use precision scale capable of measuring milligrams accurately
Sublingual administration may enhance absorption - hold under tongue 30-60 seconds
Can be taken with or without food, though empty stomach may increase absorption speed
Consider pairing with a choline source (Alpha-GPC 300mg or CDP-Choline 250mg) to prevent headaches
Store in cool, dry place away from direct sunlight and moisture","Omberacetam should be white to off-white crystalline powder without discoloration
Certificate of analysis showing purity ≥98% with HPLC verification
Sealed containers protected from moisture with desiccant packets
Tablets/capsules should contain stated amount (typically 10mg per unit)
May cause headaches if taken without adequate choline - supplement accordingly
Yellow discoloration or excessive clumping may indicate degradation or contamination","Days 1-3: Subtle cognitive clarity and mild focus enhancement; possible initial headache if not using choline
Week 1: Noticeable improvement in memory recall and verbal fluency; adjust dosing as needed
Week 2-3: Enhanced learning capacity and sustained attention; mood stabilization effects may emerge
Week 4-6: Peak cognitive benefits with improved stress resilience and mental stamina
Week 6-8: Sustained effects; consider cycle break to maintain sensitivity
Post-cycle: Gradual return to baseline over 1-2 weeks; some users report lasting improvements","Start with 10mg once daily to assess individual response before increasing dose
Always pair with a choline source (Alpha-GPC or CDP-Choline) to prevent headaches
Avoid evening dosing as cognitive stimulation may interfere with sleep
Do not combine with other strong cholinergic or glutamatergic compounds without caution
Not recommended for pregnant or breastfeeding women due to lack of safety data
Individuals with liver conditions should consult healthcare provider before use","Omberacetam demonstrated significant neuroprotective effects against Alzheimer's disease-related pathology, attenuating apoptosis and reducing tau hyperphosphorylation in human neuronal cells exposed to amyloid-beta toxicity.
Acute administration elevated BDNF mRNA levels by up to 1.4-fold and NGF mRNA by 1.3-fold in hippocampus within 3 hours post-injection, demonstrating rapid neurotrophic activity supporting neuroplasticity.
Patients with cognitive impairment from vascular cerebral damage or post-traumatic injury showed universal improvement on measured parameters. MMSE scores increased from 26 to 29 in the Omberacetam group with 1.8-fold fewer side effects compared to piracetam.",Oral tablet/capsule or sublingual powder; pair with choline source,Morning and early afternoon dosing optimal; avoid late evening due to potential alertness effects,,"Memory Enhancement
Improved memory consolidation and retrieval through enhanced synaptic plasticity and neurotrophic factor expression
Learning Acceleration
Faster acquisition of new information via AMPA receptor modulation and enhanced long-term potentiation
Focus and Concentration
Sustained attention improvements through acetylcholine sensitization and glutamatergic enhancement","Oxidative Stress Protection
Antioxidant effects protecting neurons from free radical damage and lipid peroxidation
Anti-Inflammatory Action
Reduction of neuroinflammatory processes that contribute to cognitive decline
Excitotoxicity Prevention
Protection against excessive glutamate and calcium-mediated neuronal damage",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"BDNF Upregulation
Rapid increase in brain-derived neurotrophic factor supporting neurogenesis and synaptic plasticity
NGF Enhancement
Elevated nerve growth factor expression promoting neuronal survival and differentiation
Synaptic Plasticity
Enhanced long-term potentiation and synaptic strength through glutamate receptor modulation","Complementary cognitive enhancement through different mechanisms - Semax via ACTH pathways, Omberacetam via glutamatergic/cholinergic modulation","Selank provides anxiolytic effects that may complement Omberacetam's cognitive enhancement, potentially reducing nootropic-induced anxiety",Both compounds affect neurotransmitter systems - monitor for overstimulation when combining,Both support neuroplasticity through neurotrophic mechanisms; may have additive neuroprotective effects,Both are potent cognitive enhancers affecting growth factors - potential for excessive stimulation; start with lower doses if combining,"Omberacetam increases acetylcholine sensitization; choline supplementation (Alpha-GPC, CDP-Choline) may prevent headaches and enhance effects",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Nasal,https://pep-pedia.org/peptides/omberacetam,Omberacetam (Noopept),Synthetic Dipeptide | Cognitive Enhancement Nootropic,5-15mg,Nasal,"2-4 weeks on, 2 weeks off",Refrigerated once reconstituted,5-10mg per administration,"1-2 times daily, morning preferred",,,"Onset 5-15 minutes, peak 30-60 minutes, duration 2-4 hours","Refrigerate reconstituted solution, protect from light",2-4 weeks maximum continuous use,2 weeks break between cycles,"Omberacetam (also known as Noopept or GVS-111) is a synthetic nootropic dipeptide (N-phenylacetyl-L-prolylglycine ethyl ester) developed in Russia in 1996 for its potent cognitive-enhancing and neuroprotective properties. While structurally distinct from racetams, it's considered part of the nootropic family and functions as a prodrug that converts to the active metabolite cycloprolylglycine (CPG). Research indicates it may enhance memory, learning, and neuroplasticity through BDNF/NGF upregulation and glutamatergic modulation at doses 1000x lower than piracetam.
Faster onset than oral, direct CNS access via olfactory pathway, potentially lower effective doses needed
Bypasses first-pass metabolism through direct nasal absorption, allowing faster brain penetration via olfactory and trigeminal nerve pathways",,,,,"Faster onset of nootropic effects through direct nasal-to-brain delivery
Quick-acting mental clarity for demanding cognitive tasks
Enhanced memory function with potentially more direct brain delivery","Disclaimer: These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing: Nasal route offers faster onset - ideal for acute cognitive demands",,,,,"Important: Always use bacteriostatic water (BAC). Sterile technique is essential.
Weigh desired amount of Omberacetam powder using precision scale
Dissolve in sterile saline or sterile water (typical concentration 10mg/ml)
Transfer to sterile nasal spray bottle with known spray volume
Calculate mg per spray based on spray volume and concentration
Store reconstituted solution refrigerated and use within 2-4 weeks
Shake gently before each use and alternate nostrils","Reconstituted nasal solution should be clear without particles
Accurately calculated concentration for consistent dosing
Some users may experience mild nasal discomfort - discontinue if severe
Any precipitation or cloudiness indicates contamination or degradation","Minutes 5-15: Onset of cognitive clarity faster than oral route
Hour 1: Peak effects with enhanced focus and mental alertness
Hours 2-4: Sustained cognitive support with gradual tapering
Repeated use: Build effects similar to oral administration over time","Use sterile preparation techniques to prevent infection
Start with lower doses than oral equivalent due to potentially higher bioavailability
Discontinue if persistent nasal irritation or bleeding occurs
Not suitable for those with nasal conditions or recent nasal surgery","Omberacetam demonstrated significant neuroprotective effects against Alzheimer's disease-related pathology, attenuating apoptosis and reducing tau hyperphosphorylation in human neuronal cells exposed to amyloid-beta toxicity.
Acute administration elevated BDNF mRNA levels by up to 1.4-fold and NGF mRNA by 1.3-fold in hippocampus within 3 hours post-injection, demonstrating rapid neurotrophic activity supporting neuroplasticity.
Patients with cognitive impairment from vascular cerebral damage or post-traumatic injury showed universal improvement on measured parameters. MMSE scores increased from 26 to 29 in the Omberacetam group with 1.8-fold fewer side effects compared to piracetam.",,Morning administration for cognitive enhancement; allow 15-30 minutes before demanding tasks,,"Rapid Cognitive Enhancement
Faster onset of nootropic effects through direct nasal-to-brain delivery
Acute Focus Support
Quick-acting mental clarity for demanding cognitive tasks
Memory Support
Enhanced memory function with potentially more direct brain delivery",,,,,,,,,,,,,,,,,"Nasal spray solution; alternate nostrils, breathe gently after spray",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Complementary cognitive enhancement through different mechanisms - Semax via ACTH pathways, Omberacetam via glutamatergic/cholinergic modulation","Selank provides anxiolytic effects that may complement Omberacetam's cognitive enhancement, potentially reducing nootropic-induced anxiety",Both compounds affect neurotransmitter systems - monitor for overstimulation when combining,Both support neuroplasticity through neurotrophic mechanisms; may have additive neuroprotective effects,Both are potent cognitive enhancers affecting growth factors - potential for excessive stimulation; start with lower doses if combining,"Omberacetam increases acetylcholine sensitization; choline supplementation (Alpha-GPC, CDP-Choline) may prevent headaches and enhance effects","Alternative Delivery Research
Intranasal route offers research applications for studying direct CNS effects
Bioavailability Studies
Nasal administration may provide superior brain penetration for acute effects",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Injectable,https://pep-pedia.org/peptides/ara-290,Ara 290,Tissue-Protective Peptide | Innate Repair Receptor Agonist,1-8 mg,Injectable,28 days,2-8°C,4 mg daily,Once daily,"Subcutaneous: anterior thigh, abdomen; IV: clinical setting only","Same time daily, preferably morning","Initial effects: 7-14 days, Peak benefits: 4-6 weeks, Sustained effects: 6+ months","Powder: -80°C long-term, 4°C medium-term; Reconstituted: use immediately or refrigerate up to 24 hours",28 days standard protocol,"Variable based on indication, clinical trials used single 28-day cycles","Ara 290 (Cibinetide) is an engineered 11-amino acid peptide derived from erythropoietin that activates the Innate Repair Receptor (IRR) to provide tissue-protective effects without stimulating red blood cell production. It has completed multiple Phase 2 clinical trials and holds FDA Orphan Drug status for several indications.
Proven tissue protection, nerve regeneration, anti-inflammatory effects, excellent safety profile in clinical trials
Activates Innate Repair Receptor (IRR) through EPOR/β-common receptor complex, triggering tissue-protective signaling without erythropoietic effects",,,,,"23% increase in corneal nerve fiber area demonstrated in clinical trials, with sustained improvement in neuropathic pain
Significant nerve regeneration and metabolic improvements in Type 2 diabetes patients with peripheral neuropathy
Crosses blood-brain barrier to provide neuroprotection in stroke and traumatic brain injury models","Disclaimer: These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing: Ara 290 has a short half-life (~20 minutes) but triggers long-lasting cellular effects. Morning administration may optimize circadian alignment with tissue repair processes.",,,,,"Important: Always use bacteriostatic water (BAC). Sterile technique is essential.
Allow vial to reach room temperature (15-20 minutes)
Clean vial top with alcohol swab
Slowly inject 1 mL sterile water into vial
Gently swirl to dissolve (do not shake vigorously)
Solution may appear slightly cloudy - this is normal
Use immediately or store at 2-8°C for up to 24 hours
Protect from light during storage and use
Rotate injection sites (anterior thigh recommended)","Clinical trial material manufactured under GMP conditions with full quality documentation
Correct 11-amino acid sequence (pGlu-Glu-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser) with N-terminal pyroglutamate
Proper freeze-drying with excipients like sucrose or mannitol for stability and sterility
Requires protection from light during storage, reconstitution, and administration
Certificates of analysis showing purity >95%, endotoxin levels <1 EU/mg, and sterility testing
Reconstituted solution should be clear to slightly cloudy and colorless - discoloration indicates degradation","Week 1-2: Initial anti-inflammatory effects, potential mild improvement in pain symptoms
Week 2-4: Progressive nerve regeneration, improved tissue healing markers, enhanced wound healing if applicable
Week 4-6: Peak therapeutic effects, maximum nerve fiber density improvements, sustained pain relief
Month 2-6: Long-lasting benefits continue due to ""molecular switch"" effect, sustained tissue protection","Excellent safety profile in clinical trials with no serious drug-related adverse events
No anti-drug antibodies detected in human studies
No hematopoietic effects or risk of polycythemia unlike erythropoietin
Contraindicated with recent anti-TNF therapy (within 6 months) or EPO use (within 2 months)
Monitor for injection site reactions and rotate injection sites
Not recommended during pregnancy or in patients with BMI >34 kg/m²","In vitro study of human pancreatic islets showing Ara 290 protection against inflammatory damage, supporting its potential in diabetes treatment and transplantation.
Open-label pilot study in 9 patients examining Ara 290 effects on diabetic macular edema, showing good safety profile and improved patient-reported outcomes.
Double-blind, placebo-controlled trial in 64 patients with sarcoidosis-associated small fiber neuropathy. The 4 mg dose showed significant nerve regeneration and pain reduction in moderate-severe cases.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Clinical trials included patients on antidiabetic medications including GLP-1 agonists with no adverse interactions, may provide complementary metabolic benefits",,,,,,,,,,,,,,,,,,,,,"Peripheral Nerve Regeneration
23% increase in corneal nerve fiber area demonstrated in clinical trials, with sustained improvement in neuropathic pain
Diabetic Neuropathy Treatment
Significant nerve regeneration and metabolic improvements in Type 2 diabetes patients with peripheral neuropathy
Central Nervous System Protection
Crosses blood-brain barrier to provide neuroprotection in stroke and traumatic brain injury models","Cytokine Reduction
Significantly reduces TNF-α, IL-6, and IL-12 production while maintaining tissue-protective signaling
Inflammatory Bowel Disease
Reduces colitis severity in animal models through broad anti-inflammatory mechanisms
Transplant Protection
Improves islet graft survival and reduces rejection through immunomodulatory effects","Wound Healing Enhancement
Improves re-epithelialization and angiogenesis in diabetic wound models through VEGF upregulation
Cardiovascular Protection
Reduces infarct size and improves survival in myocardial infarction models with sustained cardioprotective effects
Anti-Aging Tissue Effects
Maintains cardiac function and reduces inflammation in aging heart models through IRR activation","Rheumatoid Arthritis Treatment
Phase II trial showed significant pain reduction (VAS pain decreased 27-29mm, p=0.03) in patients with active RA, with good EULAR responses observed
Autoimmune Modulation
Reduces inflammatory cytokines and modulates immune response through IRR activation without immunosuppression","Both peptides promote tissue repair through complementary pathways - Ara 290 via IRR activation and BPC-157 via growth factor signaling, potentially enhancing wound healing and neuroprotection",Combined tissue repair mechanisms may enhance recovery from injury - Ara 290 provides anti-inflammatory effects while TB-500 promotes cellular migration and angiogenesis,"No known interactions between IRR activation and thymosin pathways, both work through different mechanisms for tissue protection and repair",Clinical trials exclude recent EPO use within 2 months due to potential receptor interference and unclear combined effects on hematopoiesis,Both affect cellular metabolism and stress response - monitor for additive anti-inflammatory effects and potential enhanced tissue protection,Both affect tissue repair and growth pathways - combination may enhance effects but requires monitoring for potential excessive growth factor activity,Clinical protocols require 6-month washout from anti-TNF therapy before Ara 290 to avoid potential immune system interactions,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Oral,https://pep-pedia.org/peptides/bioglutide,Bioglutide,NA-931 | Quadruple IGF-1/GLP-1/GIP/Glucagon Agonist,50-150mg,Oral,12+ weeks,Room temp / 2-8°C,50-150mg daily,Once daily,,,"Weight loss begins week 1-2, peak effects 12+ weeks","Room temperature, protect from moisture",12+ weeks for significant results,Per medical guidance,"Bioglutide (NA-931) is a first-in-class oral quadruple receptor agonist targeting IGF-1, GLP-1, GIP, and glucagon receptors simultaneously. Developed by Biomed Industries, this small molecule derived from a cyclic IGF-1 fragment demonstrates remarkable oral bioavailability and blood-brain barrier penetration. Phase 2 clinical trials showed up to 13.8% body weight reduction in 13 weeks while preserving muscle mass - a significant advantage over existing GLP-1 therapies. Currently in Phase 2b/3 trials for obesity and type 2 diabetes.
Oral administration (no injections), muscle-sparing weight loss, once-daily dosing with or without food, milder GI side effects than injectable GLP-1s, quadruple receptor activation for comprehensive metabolic effects.
NA-931 is a small lipophilic molecule derived from cyclic IGF-1 fragment that crosses the blood-brain barrier. Simultaneously activates IGF-1 (muscle preservation, insulin sensitivity), GLP-1 (appetite suppression, insulin secretion), GIP (glucose metabolism, fat storage), and glucagon (energy expenditure, fat oxidation) receptors.","Weight
Proprietary (small molecule)
Length
Small cyclic structure
Type
Cyclic IGF-1 fragment derivative
Amino Acid Sequence:
Proprietary - derived from cyclic glycine-proline analog of IGF-1
* Lipophilic small molecule optimized for oral bioavailability and BBB penetration",,,,"Phase 2 showed 13.8% body weight reduction at 150mg daily in 13 weeks. 72% of subjects achieved ≥12% weight loss vs 2% placebo. Supports Phase 3 development.
Unlike existing GLP-1 therapies, no muscle loss observed in clinical trials. IGF-1 receptor activation promotes protein synthesis while reducing fat mass.
Preclinical data showed 46% reduction in liver fat content. Targets metabolically harmful visceral adipose tissue.","Disclaimer: These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing: NA-931 can be taken at any time of day with or without food. Unlike oral semaglutide, no fasting period or absorption enhancer required. Half-life of 16-24 hours supports once-daily dosing.",,,No known interactions - BPC-157 may support gut health during GLP-1 therapy,,"Important: Always use bacteriostatic water (BAC). Sterile technique is essential.
NA-931 is administered as an oral capsule
Take once daily with a glass of water
Can be taken with or without food
Blood levels remain consistent regardless of fasting or fed state
No absorption enhancers required (unlike oral semaglutide)
Store at room temperature or refrigerated","Obtain from reputable research chemical suppliers with Certificate of Analysis (COA) and third-party testing.
Should be in sealed, moisture-protected container with batch number and purity information.
Capsules or tablets should be uniform in size and color with no signs of degradation.
NA-931 is an investigational compound - availability outside clinical trials is limited and unregulated.
Never use compounds from unverified sources without analytical testing confirmation.
Any color changes, moisture damage, or unusual odor indicates degradation.","Week 1-2: Possible mild appetite reduction, minimal GI effects
Week 2-4: Noticeable appetite suppression, early weight loss
Week 4-8: Steady weight loss (1-2+ lbs/week), improved energy
Week 8-13: Continued weight loss, 10-14% total reduction possible
Side effects generally milder than injectable GLP-1 therapies
Muscle mass preservation reported in clinical trials
Metabolic improvements (glucose, lipids) develop over weeks","Investigational drug - not yet FDA approved
Start at lower dose (50mg) and titrate up as tolerated
Most common side effects: mild nausea (7.3%), diarrhea (6.3-8.1%)
83% of GI adverse events rated mild or insignificant in trials
No serious drug-related adverse events in Phase 2
Caution with personal/family history of medullary thyroid carcinoma (GLP-1 class concern)
Monitor for pancreatitis symptoms (severe abdominal pain)
Drug interactions not fully characterized - avoid stacking with other GLP-1 agonists","Randomized, double-blind, placebo-controlled Phase 2 trial (NCT06564753). NA-931 showed dose-dependent weight loss up to 13.8% at 150mg daily. 72% of treated subjects achieved ≥12% weight loss vs 2% placebo. No muscle loss observed, distinguishing from existing therapies.
First-in-human study in overweight/obese subjects and T2DM patients. Demonstrated excellent safety profile with maximum 6.4% weight loss in 4 weeks. Blood levels consistent regardless of fasting or fed state. No serious adverse events reported.
Presented at EASD Vienna 2025. Maximum body weight reduction of 14.8% (13.2% placebo-adjusted). 83% of GI adverse events were mild or insignificant. Treatment-emergent adverse events predominantly mild. Supports progression to Phase 3.",N/A - Oral administration,"Any time of day, with or without food",,,,,,,,"Obesity Management
Phase 2 showed 13.8% body weight reduction at 150mg daily in 13 weeks. 72% of subjects achieved ≥12% weight loss vs 2% placebo. Supports Phase 3 development.
Muscle Preservation
Unlike existing GLP-1 therapies, no muscle loss observed in clinical trials. IGF-1 receptor activation promotes protein synthesis while reducing fat mass.
Visceral Fat Reduction
Preclinical data showed 46% reduction in liver fat content. Targets metabolically harmful visceral adipose tissue.",,,,,,,,,,,,,,,,,,,,,,,,,,Different mechanisms - CJC-1295 stimulates GH release while Bioglutide targets metabolic receptors. May complement for body composition,May help maintain metabolic rate and support muscle preservation during weight loss,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Type 2 Diabetes
Significant glycemic improvements in Phase 1/2 trials. Multi-receptor approach enhances glucose-dependent insulin secretion and insulin sensitivity.
Insulin Sensitivity
IGF-1 and GLP-1 receptor activation improves peripheral insulin sensitivity. Preclinical studies showed 23% fasting glucose reduction.
Metabolic Syndrome
Comprehensive metabolic improvement including lipid profiles - 34% triglyceride reduction observed in preclinical studies.","Energy Expenditure
Glucagon receptor activation increases basal metabolic rate and hepatic fat oxidation. Enhanced thermogenesis observed in preclinical models.
Appetite Regulation
Central action through GLP-1 receptors in hypothalamus reduces appetite. BBB penetration allows direct CNS effects.
Lipid Metabolism
GIP receptor activation improves lipid handling and promotes healthy subcutaneous fat storage over ectopic deposition.",Active clinical trial (NCT06732245) evaluating NA-931 + Tirzepatide combination for enhanced weight loss,Both activate GLP-1 receptors - combining creates redundancy and compounded GI side effects risk,"Both are multi-agonists targeting overlapping pathways (GLP-1, GIP, glucagon) - avoid stacking",NNMT inhibition may complement metabolic effects for enhanced fat loss,Different metabolic pathways - may be synergistic for fat loss and energy metabolism,,,,,,,,,,,,,,,,,,,,,
Injectable,https://pep-pedia.org/peptides/bpc-157,BPC-157,Body Protection Compound-157 | Pentadecapeptide,250-500mcg,Injectable,4-8 weeks,2-6°C,250-500 mcg,1-2x daily,"Belly, thigh, arm (near injury for localized healing)",Empty stomach preferred,"1-3 weeks for healing, 3-7 days for inflammation","Fridge 2-6°C, use within 28 days",4-12 weeks,4+ weeks,"BPC-157 is a synthetic pentadecapeptide (15 amino acids) derived from a protective protein found in human gastric juice. It's known for its remarkable healing properties and is extensively researched for tissue repair, inflammation reduction, and gastrointestinal protection. Not FDA approved and prohibited by WADA (added 2022) under S0: Non-Approved Substances - no TUE available for athletes.
Accelerated healing of tendons, ligaments, muscles, bones, and localized tissue repair. Superior bioavailability for targeted healing with anti-inflammatory effects.
Injectable BPC-157 provides direct tissue targeting and higher local concentrations. Promotes angiogenesis (formation of new blood vessels), enhances collagen synthesis, modulates growth factor expression, and provides localized protection against tissue damage.","Weight
1,419.53 Da
Length
15 amino acids
Type
Pentadecapeptide
Amino Acid Sequence:
Gly-Lys-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
* Stable gastric pentadecapeptide derived from human gastric juice",,,,"Accelerated tendon-to-bone healing and improved biomechanical properties in injury models. Most effective with localized injection.
Enhanced muscle healing and reduced recovery time following crush injuries and surgical procedures with direct tissue targeting.
Promotes blood vessel formation and improves vascularization in healing tissues through localized delivery.","Disclaimer: Commonly cycled 4-12 weeks on, 4+ weeks off in research protocols. No loading phase is typically used. Tapering is generally not reported as necessary, though some gradually reduce over the final week on longer cycles. This is not medical advice. Consult a healthcare provider before use.
Timing: Injectable BPC-157 is most effective on empty stomach. For injury healing, inject as close to the injury site as possible (subcutaneous). Rotate injection sites to prevent tissue irritation.",,,,,"Important: Always use bacteriostatic water (BAC). Sterile technique is essential.
Clean work area and hands thoroughly
Calculate required BAC water volume using calculator below
Draw BAC water into syringe
Inject slowly down vial side (not directly onto powder)
Gently swirl until dissolved (never shake)
Store in refrigerator, use within 28 days","Lyophilized powder should appear as a white, fluffy ""cake"" that fills most of the vial bottom. This indicates proper freeze-drying.
When properly mixed with BAC water, solution should be crystal clear with no particles or cloudiness.
Small clumps that dissolve completely with gentle swirling are acceptable. Shipping can cause minor compaction.
If powder appears collapsed, melted, or stuck to vial sides, it may have been exposed to heat during shipping.
Persistent cloudiness, particles, or precipitates after gentle mixing indicate degraded or contaminated peptide.","Week 1-2: Reduced inflammation and pain at injection site
Week 2-4: Improved healing rate and tissue repair
Week 4-8: Maximum localized healing benefits
Side effects: Mild injection site redness or irritation
Most effective for: Tendon, ligament, muscle injuries","May cause mild injection site reactions
Consult doctor if on blood thinners due to angiogenesis effects
Not recommended during pregnancy or breastfeeding
WADA prohibited (S0: Non-Approved Substances) - not for competitive athletes","Comprehensive study showing BPC-157's protective effects against gastric ulcers through multiple mechanisms including cytoprotection and enhanced mucosal healing.
Preclinical safety evaluation showing no serious adverse effects at therapeutic doses, establishing safety profile for potential clinical applications.
BPC-157 treatment resulted in significant functional recovery, reduced tissue damage, and improved neurological outcomes in spinal cord injury models.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Complementary healing mechanisms, often used together",,,,,,,,,,,,,"Tendon Healing
Accelerated tendon-to-bone healing and improved biomechanical properties in injury models. Most effective with localized injection.
Muscle Recovery
Enhanced muscle healing and reduced recovery time following crush injuries and surgical procedures with direct tissue targeting.
Angiogenesis
Promotes blood vessel formation and improves vascularization in healing tissues through localized delivery.","Neuroprotection
Protective effects against various neurotoxic agents and ischemic brain injury models with systemic administration.
Spinal Cord Injury
Improved functional recovery and reduced tissue damage in spinal cord injury studies via injection.
Peripheral Nerves
Enhanced peripheral nerve regeneration and functional recovery after injury with localized treatment.","Systemic GI Protection
Injectable BPC-157 provides systemic gastrointestinal protection through circulation, though oral may be more targeted for GI issues.
Ulcer Prevention
Studies show protective effects against stress-induced gastric ulcers through systemic anti-inflammatory mechanisms.
Intestinal Barrier
Supports intestinal barrier function and reduces inflammatory markers through systemic circulation.",No known negative interactions,"BPC-157 increases GH receptor expression, amplifying Ipamorelin's growth hormone benefits","BPC-157 upregulates GH receptors, enhancing CJC-1295 effectiveness for tissue repair",No known interactions - different mechanisms of action and receptor targets,"Safe combination - BPC-157 promotes tissue repair via growth factors, AOD-9604 targets fat metabolism via beta-3 adrenergic receptors. No pathway overlap. Often combined in regenerative protocols.",No known interactions - different mechanisms with BPC-157 supporting tissue repair and L-Carnitine supporting energy metabolism via fatty acid transport.,,,,,,,,,,,,
Oral,https://pep-pedia.org/peptides/bpc-157,BPC-157,Body Protection Compound-157 | Pentadecapeptide,500mcg-2mg,Oral,4-8 weeks,Room temp,500mcg-1mg,1-2x daily,,,"1-4 weeks for GI effects, 2-6 weeks for systemic","Room temp, cool dry place",4-12 weeks,4+ weeks,"BPC-157 is a synthetic pentadecapeptide (15 amino acids) derived from a protective protein found in human gastric juice. It's known for its remarkable healing properties and is extensively researched for tissue repair, inflammation reduction, and gastrointestinal protection. Not FDA approved and prohibited by WADA (added 2022) under S0: Non-Approved Substances - no TUE available for athletes.
Superior gastrointestinal protection, systemic healing effects, convenient administration. Particularly effective for digestive issues, ulcer prevention, and general wellness.
BPC-157 is remarkably stable in gastric acid and demonstrates excellent oral bioavailability. Oral administration provides direct gastrointestinal protection while delivering systemic healing effects through absorption.","Weight
1,419.53 Da
Length
15 amino acids
Type
Pentadecapeptide
Amino Acid Sequence:
Gly-Lys-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
* Stable gastric pentadecapeptide derived from human gastric juice",,,,"Studies demonstrate superior protective effects against gastric and duodenal ulcers through direct gastric contact and cytoprotective mechanisms.
Research shows acceleration of intestinal healing and reduction of inflammatory markers in IBD models through direct mucosal contact.
Evidence supports enhanced mucosal barrier function and accelerated epithelial regeneration through direct gastric administration.
Oral BPC-157 provides systemic healing effects through circulation, supporting overall tissue repair and recovery.
Systemic anti-inflammatory effects that support healing throughout the body via oral absorption.
General tissue protection and repair through systemic circulation, though may be less targeted than injectable forms.
Systemic neuroprotective effects through oral absorption, though may require higher doses than injectable forms.
Potential cognitive and neurological support through systemic circulation and gastric-brain axis.
May help modulate stress response and neurological function through gut-brain connection.","Disclaimer: Commonly cycled 4-12 weeks on, 4+ weeks off in research protocols. No loading phase is typically used. Tapering is generally not reported as necessary, though some gradually reduce over the final week on longer cycles. This is not medical advice. Consult a healthcare provider before use.
Timing: Oral BPC-157 is most effective on empty stomach, 30 minutes before meals. This allows for optimal gastric contact and absorption. Take consistently at the same times daily for best results.",,,,,"Important: Always use bacteriostatic water (BAC). Sterile technique is essential.
Use pre-made stable oral capsules (recommended for convenience)
If using powder: measure accurate dose with precision milligram scale
Fill empty capsules with measured powder if making your own
Take on empty stomach with water (30 minutes before meals)
Wait 30 minutes before eating for optimal absorption
Store capsules in cool, dry place at room temperature","Capsules should be intact with no cracks, discoloration, or moisture damage. Clear labeling with dosage information.
Sealed bottles or blister packs with clear expiration dates and batch numbers. Professional pharmaceutical packaging.
If using powder form, should appear as fine, white to off-white powder with no clumping or discoloration.
Capsules should not be sticky, discolored, or show signs of moisture exposure. Powder should not be clumped.
Avoid products that have been stored improperly (excessive heat, humidity, or light exposure).","Week 1-2: Improved digestive comfort and reduced GI irritation
Week 2-4: Enhanced gastric protection and healing
Week 4-8: Systemic healing benefits and overall wellness
Side effects: Minimal, occasionally mild GI adjustment
Most effective for: Gastric ulcers, digestive issues, general healing","Generally very well tolerated with minimal side effects
Take on empty stomach for optimal absorption
May cause mild digestive adjustment in first few days
Consult doctor if on blood thinners
Not recommended during pregnancy or breastfeeding
WADA prohibited (S0: Non-Approved Substances) - not for competitive athletes","Comprehensive study showing BPC-157's protective effects against gastric ulcers through multiple mechanisms including cytoprotection and enhanced mucosal healing.
Preclinical safety evaluation showing no serious adverse effects at therapeutic doses, establishing safety profile for potential clinical applications.
BPC-157 treatment resulted in significant functional recovery, reduced tissue damage, and improved neurological outcomes in spinal cord injury models.",Oral capsules (take with water),"Empty stomach, 30 min before meals",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Complementary healing mechanisms, often used together",,,,,,,,,,,,,,,,No known negative interactions,"BPC-157 increases GH receptor expression, amplifying Ipamorelin's growth hormone benefits","BPC-157 upregulates GH receptors, enhancing CJC-1295 effectiveness for tissue repair",No known interactions - different mechanisms of action and receptor targets,"Safe combination - BPC-157 promotes tissue repair via growth factors, AOD-9604 targets fat metabolism via beta-3 adrenergic receptors. No pathway overlap. Often combined in regenerative protocols.",No known interactions - different mechanisms with BPC-157 supporting tissue repair and L-Carnitine supporting energy metabolism via fatty acid transport.,"Ulcer Protection
Studies demonstrate superior protective effects against gastric and duodenal ulcers through direct gastric contact and cytoprotective mechanisms.
Intestinal Repair
Research shows acceleration of intestinal healing and reduction of inflammatory markers in IBD models through direct mucosal contact.
Mucosal Healing
Evidence supports enhanced mucosal barrier function and accelerated epithelial regeneration through direct gastric administration.","Systemic Healing
Oral BPC-157 provides systemic healing effects through circulation, supporting overall tissue repair and recovery.
Anti-inflammatory
Systemic anti-inflammatory effects that support healing throughout the body via oral absorption.
Tissue Protection
General tissue protection and repair through systemic circulation, though may be less targeted than injectable forms.","Neuroprotection
Systemic neuroprotective effects through oral absorption, though may require higher doses than injectable forms.
Cognitive Support
Potential cognitive and neurological support through systemic circulation and gastric-brain axis.
Stress Response
May help modulate stress response and neurological function through gut-brain connection.",,,,,,,,,
Injectable,https://pep-pedia.org/peptides/cagrilintide,Cagrilintide,Long-Acting Amylin Receptor Agonist | Weight Loss & Diabetes,2.4 mg weekly,Injectable,Continuous,-20°C,2.4 mg weekly (after 16-week dose escalation),"Once weekly, same day each week","Subcutaneous: abdomen, thigh, or upper arm (rotate weekly)","Same day weekly, preferably evening, with or without food",Initial effects: 1-2 weeks; Significant weight loss: 4-12 weeks; Peak effects: 26+ weeks,"Store frozen at -20°C, protect from light, do not shake",Continuous treatment recommended for sustained effects,Not applicable - continuous therapy for optimal efficacy,"Cagrilintide (AM833) is a novel long-acting lipidated amylin analog that acts as a dual amylin and calcitonin receptor agonist. Developed for weight management and type 2 diabetes treatment, it shows superior weight loss potential when combined with semaglutide (CagriSema), with recent Phase 3 trials demonstrating up to 22.7% weight reduction.
FDA development candidate, extensive Phase 3 data, superior weight loss in combination with semaglutide, once-weekly convenience
Subcutaneous injection provides optimal bioavailability of lipidated amylin analog, targeting dual amylin and calcitonin receptors for satiety and metabolic effects","Weight
4,409.01 Da
Length
37 amino acids
Type
Amylin receptor agonist
Amino Acid Sequence:
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH₂
* N-terminal lipidation with γ-glutamic acid spacer and C20 fatty diacid",,,,"Phase 3 trials demonstrate 22.7% weight loss with CagriSema combination, outperforming existing therapies
15.7% weight loss in diabetic patients with concurrent glycemic improvements
Long-acting formulation supports sustained weight loss throughout treatment period","Disclaimer: These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing: Administer same day each week. Evening injection may reduce morning nausea. Can be given with or without food due to subcutaneous route.",,,,,"Important: pH CRITICAL: Cagrilintide requires acidic pH (3.5-4.5) to prevent fibril formation. Standard BAC water (pH 5.5-6) is acceptable for short-term use (<30 days). For optimal long-term stability, acidify to pH ~4.0 with 0.6% acetic acid.
Reconstitute slowly down side of vial, swirl gently (don't shake)
Verify solution is clear - any cloudiness or particles indicates fibril formation, discard immediately
Store refrigerated (2-8°C), inspect for clarity before each injection
Allow to reach room temperature 15-30 minutes before injection
Inject subcutaneously in abdomen, thigh, or upper arm, rotating sites weekly","When approved, will likely be available as convenient pre-filled pen similar to other Novo Nordisk products
Clinical trial material demonstrates >98% purity with appropriate lipidation and folding
Proper frozen storage at -20°C maintains stability of lipidated peptide structure
Long-acting formulation provides stable pharmacokinetics over 7-day dosing interval
Amylin analogs have inherent tendency to form amyloid fibrils, especially at neutral or alkaline pH. Solution should remain clear - any cloudiness, visible particles, or gel-like texture indicates fibril formation and the product should be discarded immediately
Any visible particles, cloudiness, or color changes indicate protein degradation
Exposure to repeated freeze-thaw cycles or high temperatures can denature the peptide structure
Cagrilintide requires acidic formulation (pH 3.5-4.5) for optimal stability. Reconstitution with standard bacteriostatic water (pH 5.5-6) is acceptable for short-term use (<30 days refrigerated) but may cause gradual degradation. Higher pH environments can lead to deamidation and protein aggregation. Pharmaceutical formulations use pH ~4.0 for maximum stability
Currently only available in clinical trials - FDA approval expected Q1 2026","Week 1-2: Gastrointestinal adaptation period, mild nausea possible during dose escalation
Week 4-8: Early weight loss becomes apparent (2-5%), appetite reduction noticeable
Week 12-26: Significant weight loss acceleration (10-15%), improved satiety signals
Week 26+: Peak efficacy achieved (15-23% weight loss), sustained weight loss maintenance with continued therapy","Most common side effects are gastrointestinal (nausea, vomiting, diarrhea) during initial weeks
Anti-cagrilintide antibodies develop in 46-73% of patients but do not affect efficacy
No clinically significant QT prolongation observed in thorough QT studies
Only 57.3% of patients achieved maximum 2.4 mg dose in REDEFINE 1 trial
Formulation must be maintained at acidic pH (3.5-4.5) to prevent fibril formation and deamidation. Reconstituted solutions should be inspected for cloudiness or particles before each use","Landmark Phase 3 trial published in NEJM demonstrating superior weight loss with CagriSema combination in 3,417 adults with obesity, achieving primary endpoints with excellent safety profile
Phase 3 trial in 1,206 adults with type 2 diabetes and obesity published in NEJM, demonstrating significant weight loss and glycemic improvements with CagriSema
Dedicated cardiac safety study confirming no significant QT interval prolongation at supratherapeutic doses, supporting cardiovascular safety profile",,,,,,,,,,"Superior Obesity Treatment
Phase 3 trials demonstrate 22.7% weight loss with CagriSema combination, outperforming existing therapies
Type 2 Diabetes Weight Management
15.7% weight loss in diabetic patients with concurrent glycemic improvements
Sustained Weight Maintenance
Long-acting formulation supports sustained weight loss throughout treatment period","Glucose Control Enhancement
Phase 2 trials show 2.2% HbA1c reduction with CagriSema combination versus semaglutide alone
Insulin Sensitivity Improvement
Amylin receptor activation enhances insulin sensitivity and glucose metabolism
Gastric Emptying Regulation
Controlled gastric emptying improves postprandial glucose control and satiety","Dual Pathway Satiety
Amylin and calcitonin receptor activation provides robust appetite suppression via hindbrain pathways
Food Preference Modulation
Central nervous system effects influence food choices and eating behaviors
Early Satiation Induction
Promotes feeling of fullness with smaller meal portions, supporting caloric restriction",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CagriSema combination demonstrates enhanced weight loss (22.7% vs 16.1% semaglutide alone) and improved glycemic control through complementary GLP-1 and amylin pathways.,No known direct interactions. Both are effective weight loss agents with different mechanisms - cagrilintide targets amylin/calcitonin receptors while tirzepatide targets GLP-1/GIP receptors.,"Both cause significant GI effects (gastroparesis, nausea). Cagrilintide (amylin agonist) and Retatrutide (triple GLP-1/GIP/glucagon agonist) have different mechanisms but compounded GI side effects create substantial risk. Not recommended without specialist supervision.",Phase 2 trials show similar efficacy profiles with no adverse interactions. Both GLP-1 agonists and amylin analogs work through distinct satiety pathways.,Monitor glucose levels closely as cagrilintide affects gastric emptying and may alter insulin absorption timing. May require insulin dose adjustments in diabetic patients.,Well-tolerated combination demonstrated in Phase 2/3 trials. No pharmacokinetic interactions observed between cagrilintide and metformin.,Clinical trials included patients on SGLT2 inhibitors with no safety concerns. Both mechanisms complement each other for diabetes and weight management.,Both are amylin receptor agonists with overlapping mechanisms. Combination would provide no additional benefit and may increase risk of gastrointestinal side effects.,Delayed gastric emptying may affect absorption of oral contraceptives. Space administration by 1 hour before cagrilintide injection.
